<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s40168-019-0704-8</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="review-article" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">40168</journal-id><journal-title-group><journal-title>Microbiome</journal-title><abbrev-journal-title abbrev-type="publisher">Microbiome</abbrev-journal-title></journal-title-group><issn pub-type="epub">2049-2618</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s40168-019-0704-8</article-id><article-id pub-id-type="manuscript">704</article-id><article-id pub-id-type="doi">10.1186/s40168-019-0704-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="Au1"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6921-7094</contrib-id><name><surname>Oliphant</surname><given-names>Kaitlyn</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="corresp" rid="IDs4016801907048_cor1">a</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Allen-Vercoe</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8198</institution-id><institution-id institution-id-type="GRID">grid.34429.38</institution-id><institution content-type="org-division">Department of Molecular and Cellular Biology</institution><institution content-type="org-name">University of Guelph</institution></institution-wrap><addr-line content-type="street">50 Stone Rd E</addr-line><addr-line content-type="postcode">N1G 2W1</addr-line><addr-line content-type="city">Guelph</addr-line><addr-line content-type="state">ON</addr-line><country country="CA">Canada</country></aff></contrib-group><author-notes><corresp id="IDs4016801907048_cor1"><label>a</label><email>koliphan@uoguelph.ca</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>13</day><month>6</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>7</volume><issue seq="91">1</issue><elocation-id>91</elocation-id><history><date date-type="registration"><day>28</day><month>5</month><year>2019</year></date><date date-type="received"><day>31</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>28</day><month>5</month><year>2019</year></date><date date-type="online"><day>13</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><p id="Par1">The human gut microbiome is a critical component of digestion, breaking down complex carbohydrates, proteins, and to a lesser extent fats that reach the lower gastrointestinal tract. This process results in a multitude of microbial metabolites that can act both locally and systemically (after being absorbed into the bloodstream). The impact of these biochemicals on human health is complex, as both potentially beneficial and potentially toxic metabolites can be yielded from such microbial pathways, and in some cases, these effects are dependent upon the metabolite concentration or organ locality. The aim of this review is to summarize our current knowledge of how macronutrient metabolism by the gut microbiome influences human health. Metabolites to be discussed include short-chain fatty acids and alcohols (mainly yielded from monosaccharides); ammonia, branched-chain fatty acids, amines, sulfur compounds, phenols, and indoles (derived from amino acids); glycerol and choline derivatives (obtained from the breakdown of lipids); and tertiary cycling of carbon dioxide and hydrogen. Key microbial taxa and related disease states will be referred to in each case, and knowledge gaps that could contribute to our understanding of overall human wellness will be identified.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Human gut microbiome</kwd><kwd>Microbial metabolism</kwd><kwd>Macronutrients</kwd><kwd>Human health</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>National Institutes of Health</institution><institution-id institution-id-type="doi" vocab="open-funder-registry">http://dx.doi.org/10.13039/100000002</institution-id></institution-wrap></funding-source><award-id award-type="FundRef grant">4R33AI121575-03</award-id><principal-award-recipient><name><surname>Allen-Vercoe</surname><given-names>Emma</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>5</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>28</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/40168_2019_Article_704.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>ReviewPaper</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Biomedicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Bioinformatics</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Microbial Ecology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Microbial Genetics and Genomics</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Virology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Biomedical and Life Sciences</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="ESMHint"><title>Electronic supplementary material</title><p>The online version of this article (<ext-link xlink:href="https://doi.org/10.1186/s40168-019-0704-8" ext-link-type="doi">https://doi.org/10.1186/s40168-019-0704-8</ext-link>) contains supplementary material, which is available to authorized users.</p></notes></front><body><sec id="Sec1"><title>Introduction</title><p id="Par13">The human gut microbiota is a complex ecosystem of microorganisms that inhabits and critically maintains homeostasis of the gastrointestinal (GI) tract [<xref ref-type="bibr" rid="CR1">1</xref>]. Most of the contributions made by the gut microbiota to the physiology of the human superorganism are related to microbial metabolism [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>], with bacteria being the largest of these contributors to ecosystem functioning in terms of relative genetic content [<xref ref-type="bibr" rid="CR2">2</xref>]. In general, microbial metabolism of both exogenous and endogenous substrates to nutrients useable by the host is the direct benefit, but metabolites can also act to modulate the immune system through impacting the physiology and gene expression of host cells [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. The colon is the major site of this fermentation, as its relatively high transit time and pH coupled with low cell turnover and redox potential presents more favorable conditions for the proliferation of bacteria [<xref ref-type="bibr" rid="CR7">7</xref>]. However, that does not preclude the importance of the microbiota at other sites, as for example, the small intestinal microbiota has been shown to regulate nutrient absorption and metabolism conducted by the host [<xref ref-type="bibr" rid="CR8">8</xref>]. Further, the presence of diverse metabolic activity can allow the microbiota to maximally fill the available ecological niches and competitively inhibit colonization by pathogens at all sites [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. The elevated concentrations of the mostly acidic fermentation by-products also locally reduce the pH to create a more inhospitable environment for these incoming invaders [<xref ref-type="bibr" rid="CR11">11</xref>]. However, specific fermentation pathways carried out by gut microbes can result in the formation of toxic compounds that have the potential to damage the host epithelium and cause inflammation [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par14">The three macronutrients consumed in the human diet, carbohydrates, proteins, and fat, can reach the colon upon either escaping primary digestion once the amount consumed exceeds the rate of digestion, or resisting primary digestion altogether due to the inherent structural complexity of specific biomolecules [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. Several factors can influence digestive efficiency, which in turn modulates the substrates available to the gut microbiota for consumption, including the form and size of the food particles (affected by cooking and processing), the composition of the meal (affected by the relative ratios of macronutrients and presence of anti-nutrients such as α-amylase inhibitors), and transit time [<xref ref-type="bibr" rid="CR17">17</xref>]. Transit time in particular has been shown to increase the richness and alter the composition of fecal microbial communities [<xref ref-type="bibr" rid="CR18">18</xref>], which itself results from several variables including diet, physical activity, genetics, drugs (e.g., caffeine and alcohol), and psychological status [<xref ref-type="bibr" rid="CR19">19</xref>]. The bioavailability of micronutrients to the host can also be influenced by gut microbial metabolic processes. Colonic bacteria can endogenously synthesize essential co-factors for host energy metabolism and regulation of gene expression, such as B vitamins [<xref ref-type="bibr" rid="CR20">20</xref>]. Another example includes the biotransformation of exogenous plant-derived polyphenols that have anti-oxidant, anti-cancer, and/or anti-inflammatory properties by the gut microbiota, which improves their uptake by the host [<xref ref-type="bibr" rid="CR21">21</xref>]. The following review articles on micronutrients are recommended to readers since this topic encompasses a wide scope of material [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], as such, the predominant food sources that act as precursors for the most highly concentrated metabolites will be the focus of discussion here. The aim of this review is thus to describe the major microbial fermentation by-products derived from macronutrients and their subsequent impacts on host health.</p></sec><sec id="Sec2"><title>Primary degradation</title><p id="Par15">Dietary polysaccharides can be interlinked in complex ways through a diverse array of bonds between monosaccharide units, reflected by the sheer number of carbohydrate-activating enzymes reported to have been found in the human gut microbiome [<xref ref-type="bibr" rid="CR22">22</xref>]. For example, <italic>Bacteroides thetaiotaomicron</italic> possesses 260 glycoside hydrolases in its genome alone [<xref ref-type="bibr" rid="CR23">23</xref>], which emphasizes the evolutionary requirement for adaptation in order to maximize utilization of resistant starch and the assortment of fibers available as part of the human diet. In contrast, human cells produce very few of these enzymes (although they do produce amylase to remove α-linked sugar units from starch and can use sugars such as glucose, fructose, sucrose, and lactose in the small intestine) and so rely on gut microbes to harvest energy from the remaining complex carbohydrates [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. However, once the rate-limiting step of primary degradation is surpassed, the resulting monosaccharides can be rapidly consumed by the gut microbiota with often little interconversion necessary for substrates to enter the Embden-Meyerhof-Parnas pathway, Entner-Doudoroff pathway, or Pentose phosphate pathway for pyruvate and subsequent ATP production [<xref ref-type="bibr" rid="CR25">25</xref>]. Conversely, dietary proteins are characterized by conserved peptide bonds that can be broken down by proteases; gut bacteria can produce aspartic-, cysteine-, serine-, and metallo-proteases, but in a typical fecal sample, these bacterial enzymes are far outnumbered by proteases arising from human cells [<xref ref-type="bibr" rid="CR26">26</xref>]. However, the 20 proteinogenic amino acid building blocks require more interconversion steps for incorporation into biochemical pathways in comparison to monosaccharide units, and thus it is not typical for a given gut microbial species to have the capacity to ferment all amino acids to produce energy [<xref ref-type="bibr" rid="CR27">27</xref>]. Additionally, microbial incorporation of amino acids from the environment into anabolic processes would conserve more energy in comparison to their catabolic use, by relieving the necessity for amino acid biosynthesis [<xref ref-type="bibr" rid="CR13">13</xref>]. It is for this reason that amino acids are generally not considered to be as efficient of an energy source as carbohydrates for human gut-associated microbes, and thus no surprise that the gut microbiota preferentially consume carbohydrates over proteins depending on the ratio presented to them [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. This metabolic hierarchy is analogous to human cells such as intestinal epithelial cells (IECs), in which increased amounts of autophagy occurs when access to microbially derived nutrients is scarce, as shown in germ-free mouse experiments [<xref ref-type="bibr" rid="CR30">30</xref>]. However, there are notable exceptions to this general rule, as certain species of bacteria have adopted an asaccharolytic lifestyle, likely as a strategy to evade competition (examples included in Table <xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Major genera present in the human gut microbiome and their metabolisms</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Phylum</p></th><th><p>Family</p></th><th><p>Genus</p></th><th><p>Substrates</p></th><th><p>Metabolism</p></th><th><p>End products</p></th></tr></thead><tbody><tr><td><p>Actinobacteria</p></td><td><p>Bifidobacteriaceae</p></td><td><p><italic><underline>Bifidobacterium</underline></italic></p></td><td><p>Dietary carbohydrates</p><p>HMO</p><p>Mucin</p></td><td><p>Bifid shunt pathway</p></td><td><p>Acetate</p><p>Ethanol</p><p>Formate</p><p>Lactate</p></td></tr><tr><td><p>Bacteroidetes</p></td><td><p>Bacteroidaceae</p></td><td><p><bold><italic>Bacteroides</italic></bold></p></td><td><p>Dietary carbohydrates</p><p>HMO</p><p>Mucin</p><p>Proteins</p><p>Succinate</p></td><td><p>1,2-Propanediol pathway<sup>I</sup></p><p>Acetate production</p><p>Ethanol production</p><p>Succinate pathway</p></td><td><p>1,2-Propanediol</p><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Propionate</p><p>Succinate</p></td></tr><tr><td/><td><p>Porphyromonadaceae</p></td><td><p><bold><italic>Parabacteroides</italic></bold><sup>W</sup></p></td><td><p>Dietary carbohydrates</p><p>Proteins</p><p>Succinate</p></td><td><p>Acetate production</p><p>Succinate pathway</p></td><td><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Formate</p><p>Propionate</p><p>Succinate</p></td></tr><tr><td/><td><p>Prevotellaceae</p></td><td><p><bold><italic>Prevotella</italic></bold><sup>NW</sup></p></td><td><p>Dietary carbohydrates</p><p>Proteins</p><p>Succinate</p></td><td><p>Acetate production</p><p>Succinate pathway<sup>I/A</sup></p></td><td><p>Acetate</p><p>Formate</p><p>Propionate</p><p>Succinate</p></td></tr><tr><td/><td><p>Rikencellaceae</p></td><td><p><bold><italic>Alistipes</italic></bold><sup>W</sup></p></td><td><p>Dietary carbohydrates</p><p>Proteins</p><p>Succinate</p></td><td><p>Acetate production</p><p>Succinate pathway</p></td><td><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Formate</p><p>Propionate</p><p>Succinate</p></td></tr><tr><td><p>Firmicutes</p></td><td><p><bold>Clostridiaceae</bold></p></td><td><p><italic>Clostridium</italic></p><p>(<italic>Clostridium</italic> cluster I)</p></td><td><p>Ethanol and Propionate</p><p>Lactate</p><p>Proteins</p><p>Saccharides</p></td><td><p>1,2-Propanediol pathway<sup>I</sup></p><p>Acetate production</p><p>Acrylate pathway</p><p>Butyrate kinase pathway</p><p>Ethanol production</p><p>Lactate production</p><p>Valerate production</p></td><td><p>1,2-Propanediol</p><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p><p>Propionate</p><p>Butyrate</p><p>Valerate</p></td></tr><tr><td/><td><p>Eubacteriaceae</p></td><td><p><italic><underline>Eubacterium</underline></italic></p></td><td><p>Acetate</p><p>Carbon dioxide and hHydrogen</p><p>Formate</p><p>Lactate</p><p>Methanol</p><p>Proteins</p><p>Saccharides</p></td><td><p>Acetogenesis</p><p>Acetate production</p><p>Butyryl c CoA transferase pathway</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Butyrate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p></td></tr><tr><td/><td><p><bold>Erysipelotrichaceae</bold></p></td><td><p><italic>Erysipelatoclostridium</italic></p></td><td><p>Proteins</p><p>Saccharides</p></td><td><p>Acetate production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Formate</p><p>Lactate</p></td></tr><tr><td/><td><p><bold>Lachnospiraceae</bold></p></td><td><p><bold><italic>Blautia</italic></bold></p><p>(<italic>Clostridium</italic> cluster XIVa)</p></td><td><p>1,2-Propanediol</p><p>Carbon dioxide and Hydrogen</p><p>Dietary carbohydrates</p><p>Formate</p><p>Mucin</p></td><td><p>1,2-Propanediol pathway</p><p>Acetogenesis</p><p>Acetate production</p><p>Ethanol production</p><p>Lactate production</p><p>Succinate pathway<sup>I</sup></p></td><td><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p><p>Propanol</p><p>Propionate</p><p>Succinate</p></td></tr><tr><td/><td/><td><p><bold><italic>Coprococcus</italic></bold></p><p>(<italic>Clostridium</italic> cluster XIVa)</p></td><td><p>Acetate</p><p>Dietary carbohydrates</p><p>Lactate</p></td><td><p>Acrylate pathway</p><p>Butyrate kinase pathway</p><p>Butyryl CoA:acetyl CoA transferase pathway</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Butyrate</p><p>Ethanol</p><p>Carbon dioxide and Hydrogen</p><p>Formate</p><p>Lactate</p><p>Propionate</p></td></tr><tr><td/><td/><td><p><bold><italic>Dorea</italic></bold></p><p>(<italic>Clostridium</italic> cluster XIVa)</p></td><td><p>Dietary carbohydrates</p></td><td><p>Acetate production</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p></td></tr><tr><td/><td/><td><p><bold><italic>Lachnoclostridium</italic></bold></p><p>(<italic>Clostridium</italic> cluster XIVa)</p></td><td><p>Proteins</p><p>Saccharides</p></td><td><p>Acetate production</p><p>Butyrate kinase pathway</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Butyrate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p></td></tr><tr><td/><td/><td><p><bold><italic>Roseburia</italic></bold></p><p>(<italic>Clostridium</italic> cluster XIVa)</p></td><td><p>1,2-Propanediol</p><p>Acetate</p><p>Dietary carbohydrates</p></td><td><p>1,2-Propanediol pathway</p><p>Acetate production</p><p>Butyryl CoA:acetyl CoA transferase pathway</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Butyrate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p><p>Propanol</p><p>Propionate</p></td></tr><tr><td/><td><p>Lactobacillaceae</p></td><td><p><italic><underline>Lactobacillus</underline></italic></p></td><td><p>1,2-Propanediol</p><p>Saccharides</p></td><td><p>1,2-Propanediol pathway</p><p>Acetate production</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Ethanol</p><p>Formate</p><p>Lactate</p><p>Propanol</p><p>Propionate</p></td></tr><tr><td/><td><p><bold>Ruminococcaceae</bold></p></td><td><p><bold><italic>Faecalibacterium</italic></bold></p><p>(<italic>Clostridium</italic> cluster IV)</p></td><td><p>Acetate</p></td><td><p>Butyryl CoA:acetyl CoA transferase pathway</p></td><td><p>Butyrate</p><p>Carbon dioxide and Hydrogen</p><p>Formate</p></td></tr><tr><td/><td/><td><p><bold><italic>Ruminiclostridium</italic></bold><sup>W</sup></p><p>(Specifically <italic>Clostridium</italic> cluster IV, which is currently grouped with <italic>Clostridium</italic> cluster III)</p></td><td><p>Dietary carbohydrates</p><p>Proteins</p></td><td><p>Acetate production</p><p>Butyrate kinase pathway</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Butyrate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p></td></tr><tr><td/><td/><td><p><italic>Ruminococcus</italic></p><p>(<italic>Clostridium</italic> cluster IV)</p></td><td><p>Dietary carbohydrates</p></td><td><p>Acetate production</p><p>Ethanol production</p><p>Lactate production</p><p>Succinate pathway<sup>I</sup></p></td><td><p>Acetate</p><p>Ethanol</p><p>Formate</p><p>Lactate</p><p>Succinate</p></td></tr><tr><td/><td><p>Streptococcaceae</p></td><td><p><bold><italic>Streptococcus</italic></bold><sup>NW</sup></p></td><td><p>Mucin</p><p>Saccharides</p></td><td><p>Acetate production</p><p>Ethanol production</p><p>Lactate production</p></td><td><p>Acetate</p><p>Ethanol</p><p>Formate</p><p>Lactate</p></td></tr><tr><td/><td><p><bold>Veillonellaceae</bold></p></td><td><p><italic>Veillonella</italic></p></td><td><p>1,2-Propanediol</p><p>Lactate</p><p>Proteins</p><p>Saccharides</p><p>Succinate</p></td><td><p>1,2-Propanediol pathway</p><p>Acetate production</p><p>Lactate production</p><p>Succinate pathway</p></td><td><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Formate</p><p>Lactate</p><p>Propanol</p><p>Propionate</p><p>Succinate</p></td></tr><tr><td><p>Proteobacteria</p></td><td><p>Enterobacteriaceae</p></td><td><p><italic><underline>Escherichia</underline></italic></p></td><td><p>Proteins</p><p>Saccharides</p></td><td><p>1,2-Propanediol pathway<sup>I</sup></p><p>2,3-Butanediol production</p><p>Acetate production</p><p>Ethanol production</p><p>Lactate production</p><p>Succinate pathway<sup>I</sup></p></td><td><p>1,2-Propanediol</p><p>2,3-Butanediol</p><p>Acetate</p><p>Carbon dioxide and Hydrogen</p><p>Ethanol</p><p>Formate</p><p>Lactate</p><p>Succinate</p></td></tr></tbody></table><table-wrap-foot><p>Taxa that are listed as part of a ‘core’ gut microbiota found by Falony et al. are in bold [<xref ref-type="bibr" rid="CR31">31</xref>]. Those genera that were core components of exclusively the ‘Western’ cohorts are denoted with a ‘W’ superscript, whereas the exclusively ‘non-Western’ ones are denoted with a ‘NW’ superscript. If the core taxon could not be resolved to the genus level, the bacterial families are bolded. For the bacterial families that do not already contain several core genera, the most commonly described genus of the human gut microbiome for that family is also listed as a representative. Additionally, genera found to be highly prevalent among the human population, yet typically present in low abundance, are underlined [<xref ref-type="bibr" rid="CR32">32</xref>]. The possible substrates consumed, metabolisms, and metabolites for each genus are listed. These metabolisms were inferred from the following articles [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR61">61</xref>]. Note that many of these metabolisms are species-specific, and only the substrates commonly utilized among species of the genus are listed. Further, only the most abundant metabolites produced from pyruvate catabolism (i.e., saccharolytic processes) are given. When a particular metabolic pathway is denoted with an ‘I’ superscript, the microorganisms do not possess the full enzymatic pathway, but rather produce the typical intermediate as an end-product instead. Likewise, an ‘I/A’ indicates species of that genus may possess either the full or half pathway</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec3"><title>Pyruvate metabolism</title><p id="Par16">Once pyruvate is produced, primarily from carbohydrates but also from other substrates, the human gut microbiota has developed several fermentation strategies to further generate energy, which are depicted in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. Pyruvate can either be catabolized into succinate, lactate, or acetyl-CoA. However, these intermediates do not reach high concentrations in typical fecal samples, as they can be further metabolized by cross-feeders, producing the short-chain fatty acids (SCFAs) acetate, propionate, and butyrate (Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR33">33</xref>]. These fecal metabolites are the most abundant and well-studied microbial end-products, since their effects are physiologically important: for example, host intestinal epithelial cells (IECs) utilize them as a source of fuel [<xref ref-type="bibr" rid="CR62">62</xref>]. Indeed, SCFAs contribute approximately 10% of the caloric content required by the human body for optimal functioning [<xref ref-type="bibr" rid="CR63">63</xref>]. Butyrate is the most preferred source of energy in this respect; its consumption improves the integrity of IECs by promoting tight junctions, cell proliferation, and increasing mucin production by Goblet cells [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. Butyrate also exhibits anti-inflammatory effects, through stimulating both IECs and antigen presenting cells (APCs) to produce the cytokines TGF-β, IL-10, and IL-18, and inducing the differentiation of naïve T cells to T regulatory cells [<xref ref-type="bibr" rid="CR65">65</xref>]. Acetate and propionate can also be consumed by IECs (though to a much lesser degree than butyrate) and have some anti-inflammatory effects [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. Both acetate and propionate can dampen pro-inflammatory cytokine production mediated by toll-like receptor (TLR) 4 stimulation, and propionate, similar to butyrate, can induce the differentiation of T cells to T regulatory cells [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Excess SCFAs that are not metabolized by IECs are transported via the hepatic vein to the liver, where they can be incorporated as precursors into gluconeogenesis, lipogenesis, and cholesterologenesis [<xref ref-type="bibr" rid="CR62">62</xref>]. Specifically, propionate is gluconeogenic, whereas acetate and butyrate are lipogenic. The ratio of propionate to acetate is thought to be particularly important, as propionate can inhibit the conversion of acetate to cholesterol and fat [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR66">66</xref>]. Indeed, propionate administration alone can reduce intra-abdominal tissue accretion and intrahepatocellular lipid content in overweight adults [<xref ref-type="bibr" rid="CR67">67</xref>]. The role(s) of SCFAs in glucose homeostasis is/are not yet fully elucidated, although preliminary work has additionally suggested a beneficial effect, since plasma insulin levels are inversely related to serum acetate concentrations [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR68">68</xref>].<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>Strategies of pyruvate catabolism by the human gut microbiome. Carbohydrates are first degraded to pyruvate. Pyruvate may then be converted to succinate, lactate, acetyl CoA + formate/carbon dioxide + hydrogen, ethanol, or 2,3-butanediol. Succinate may, however, also be a direct product of carbohydrate fermentation. Succinate and lactate do not typically reach high concentrations in fecal samples, as they can be further catabolized to produce energy, but certain species do secrete them as their final fermentation end-product, which enables cross-feeding. Acetate is produced by two pathways; (1) through direct conversion of acetyl CoA for the generation of energy (brown) or (2) acetogenesis (red). Formate/carbon dioxide + hydrogen can also be substrates for methanogenesis. Propionate is produced by three pathways; (1) the succinate pathway (orange), (2) the acrylate pathway (green), or (3) the 1,2-propanediol pathway (blue). 1,2-Propanediol is synthesized from lactaldehyde or dihydroxyacetone phosphate, which both are products of deoxy sugar fermentation (e.g., fucose, rhamnose). Alternatively, lactaldehyde can be produced from lactate, or 1,2-propanediol can be fermented to propanol. Propionate can be coupled with ethanol for fermentation to valerate (gray). The precursor for butyrate, butyryl CoA, is generated from either acetyl CoA or succinate. Butyrate is then produced by two pathways; (1) the butyrate kinase pathway (pink) or (2) the butyryl CoA:acetyl CoA transferase pathway (purple). Butyrate-producing bacteria may also cross-feed on lactate, converting it back to pyruvate. Lactate may also be catabolized as part of sulfate reduction</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/40168_2019_704_Fig1_HTML.png" id="MO1"/></p></fig></p><p id="Par17">In addition to SCFAs, small but significant amounts of alcohols, including ethanol, propanol, and 2,3-butanediol, can be formed as end-products of pyruvate fermentation (Table <xref rid="Tab1" ref-type="table">1</xref>; Fig. <xref rid="Fig1" ref-type="fig">1</xref>). A further alcohol, methanol, is also produced by the gut microbiota as a result of pectin degradation, demethylation of endogenous cellular proteins for regulation, or vitamin B<sub>12</sub> synthesis [<xref ref-type="bibr" rid="CR69">69</xref>] rather than fermentation. Alcohols are transported to the liver, where the detoxification process involves their conversion to SCFAs, although through pathways that yield toxic aldehydes as precursors [<xref ref-type="bibr" rid="CR69">69</xref>–<xref ref-type="bibr" rid="CR71">71</xref>]. Higher concentrations of endogenous alcohols are thus thought to be a contributing factor to the development of non-alcoholic fatty liver disease (NAFLD) [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. Proteobacteria are known to be particularly capable of alcohol generation [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR72">72</xref>], and are, interestingly, positively associated with dysbiosis in inflammatory bowel disease (IBD) [<xref ref-type="bibr" rid="CR73">73</xref>], a disease in which patients are predisposed to developing NAFLD [<xref ref-type="bibr" rid="CR74">74</xref>]. However, alcohols can also be detoxified by many members of the gut microbiota via pathways similar to those present in mammalian cells, regulating their concentration [<xref ref-type="bibr" rid="CR69">69</xref>]. Additionally, methanol can be used as a substrate for methanogenesis or acetogenesis [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR75">75</xref>], and ethanol can be coupled to propionate for fermentation to the SCFA, valerate (Table <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR36">36</xref>]. Valerate is a poorly studied metabolite, but it has been shown to inhibit growth of cancerous cells [<xref ref-type="bibr" rid="CR76">76</xref>] and to prevent vegetative growth of <italic>Clostridioides difficile</italic> both in vitro and in vivo [<xref ref-type="bibr" rid="CR36">36</xref>].</p></sec><sec id="Sec4"><title>Hydrogenotrophy</title><p id="Par18">The human body may rapidly absorb SCFAs and alcohols, which helps to reduce their nascent concentrations within the colon, allowing for continued favorable reaction kinetics [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR77">77</xref>] . In addition, the gaseous fermentation by-products, carbon dioxide and hydrogen, must also be removed to help drive metabolism forward. The utilization of these substrates is mainly the result of cross-feeding between gut microbiota members, rather than host absorption. Three main strategies for this activity exist in the human gut: (1) acetogens, for example, <italic>Blautia</italic> spp., convert carbon dioxide plus hydrogen to acetate (further examples included in Table <xref rid="Tab1" ref-type="table">1</xref>); (2) methanogens, namely archaea such as <italic>Methanobrevibacter</italic>, convert carbon dioxide plus hydrogen to methane; and (3) sulfate reducing bacteria, including <italic>Desulfovibrio</italic>, convert sulfate plus hydrogen to hydrogen sulfide [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. A higher abundance of these cross-feeders may improve the overall efficiency of metabolism in the gut; for example, an increase in methanogens is observed in the GI tract of anorexia nervosa patients, which may be a coping strategy by the gut microbiota in response to a lack of food sources [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. Sulfate-reducing bacteria are the most efficient of the hydrogenotrophs, but require a source of sulfate; in the gut, the most prominent source of sulfate is sulfated glycans [<xref ref-type="bibr" rid="CR80">80</xref>]. Although some of these glycans may be obtained from the diet, the most accessible source is mucin produced by the host [<xref ref-type="bibr" rid="CR38">38</xref>]. Sulfate-reducing bacteria obtain sulfate from these substrates via cross-feeding with microbes such as <italic>Bacteroides</italic>, which produce sulfatases [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>]<italic>.</italic> Hydrogen sulfide is both directly toxic to IECs through inhibition of mitochondrial cytochrome C oxidase, and pro-inflammatory via activation of T helper 17 cells [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. Hydrogen sulfide can additionally directly act on disulfide bonds in mucin to further facilitate mucin degradation [<xref ref-type="bibr" rid="CR84">84</xref>]. Elevated hydrogen sulfide concentrations and increased proportions of sulfate-reducing bacteria are reported in IBD [<xref ref-type="bibr" rid="CR85">85</xref>].</p></sec><sec id="Sec5"><title>Catabolism of amino acids</title><p id="Par19">The digestibility of proteins by the host is more variable than that of carbohydrates and fats, and is influenced by the previously mentioned factors of food processing, macronutrient ratios, and transit time [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], in addition to its source (e.g., plant or animal), which also leads to different amino acid compositions available to the gut microbiota [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. The extra steps of interconversion required for amino acid fermentation yield a large diversity of by-products. Protein catabolism in the gut generally has a negative connotation, as compounds that are toxic to the host can result from this process, including amines, phenols/indoles, and sulfurous compounds [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR14">14</xref>]. However, it is important to note that not all amino acids are fermented to toxic products as a result of gut microbial activity; in fact, the most abundant end products are SCFAs [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Therefore, it may not be protein catabolism per se that negatively impacts the host, but instead specific metabolisms or overall increased protein fermentation activity. It is thus important to examine these subtleties. A microbe can exhibit one of two strategies for the initial step of amino acid catabolism, either deamination to produce a carboxylic acid plus ammonia or decarboxylation to produce an amine plus carbon dioxide [<xref ref-type="bibr" rid="CR12">12</xref>]. Ammonia can inhibit mitochondrial oxygen consumption and decrease SCFA catabolism by IECs, which has led to the assumption that excess ammonia production can negatively impact the host [<xref ref-type="bibr" rid="CR87">87</xref>–<xref ref-type="bibr" rid="CR89">89</xref>]. However, the gut microbiota also rapidly assimilates ammonia into microbial amino acid biosynthetic processes [<xref ref-type="bibr" rid="CR13">13</xref>], and host IECs can additionally control ammonia concentration through conversion to citrulline and glutamine, or through slow release into the bloodstream [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. It is thus unclear how much protein catabolism is necessary to achieve toxic ammonia concentrations, and this may vary between hosts. This uncertainty, coupled with the multiple negative impacts amines can have on the host (discussed below), have led to speculation that deamination would improve host outcomes. Fortunately, deamination appears to be the more common strategy of amino acid catabolism by the gut microbiota, because high concentrations of SCFAs are produced from amino acid degradation via this pathway [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. The next steps depend on the class of amino acid starting substrate, with most eventually resulting in tricarboxylic acid cycle intermediates, pyruvate, or coenzyme A-linked SCFA precursors [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. An exception would be the series of Stickland reactions exhibited by certain Clostridia<italic>,</italic> in which a coupled oxidation and reduction of two amino acids occurs as an alternative to using hydrogen ions as the electron acceptor [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Phosphate is simultaneously added to the reduced amino acid in this case, and thus oxidative phosphorylation for the production of ATP can occur directly from the resultant acyl phosphate. In turn, branched-chain fatty acids (BCFAs), such as isovalerate and isobutyrate, can be produced as end-products. Additionally, some gut microbial species, mainly from the class Bacilli, also possess a specialized branched-chain keto acid dehydrogenase complex to yield energy from the oxidized forms of the branched-chain amino acids directly, which also leads to BCFA production [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. The major SCFA and BCFA products generated from degradation of each amino acid are presented in Table <xref rid="Tab2" ref-type="table">2</xref>. BCFAs are often used as a biomarker of protein catabolism, with the promoted goal to reduce their concentration in order to improve health outcomes [<xref ref-type="bibr" rid="CR14">14</xref>]. However, little is actually known about the impact of BCFAs on host health. In fact, preliminary work has shown that BCFAs are able to modulate glucose and lipid metabolism in the liver similarly to SCFAs [<xref ref-type="bibr" rid="CR93">93</xref>], and isobutyrate can be used as a fuel source by IECs when butyrate is scarce [<xref ref-type="bibr" rid="CR94">94</xref>]. What is undisputed, however, are the negative consequences of the pro-inflammatory, cytotoxic, and neuroactive compounds yielded from the sulfur-containing, basic and aromatic amino acids.<table-wrap id="Tab2"><label>Table 2</label><caption xml:lang="en"><p>Major products of amino acid fermentation by the human gut microbiota</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Amino acid</p></th><th><p>Amino acid class</p></th><th><p>Major products</p></th></tr></thead><tbody><tr><td><p>Aspartate</p></td><td><p>Acidic</p></td><td><p><underline>Propionate</underline></p></td></tr><tr><td><p>Glutamate</p></td><td><p>Acidic</p></td><td><p><underline>Acetate</underline>, <underline>Butyrate</underline></p></td></tr><tr><td><p>Alanine</p></td><td><p>Aliphatic</p></td><td><p>Acetate, Propionate, <underline>Butyrate</underline></p></td></tr><tr><td><p>Glycine</p></td><td><p>Aliphatic</p></td><td><p><underline>Acetate</underline></p><p>Methylamine</p></td></tr><tr><td><p>Isoleucine</p></td><td><p>Aliphatic</p></td><td><p><underline>2-Methylbutyrate</underline> or converted to Valine</p></td></tr><tr><td><p>Leucine</p></td><td><p>Aliphatic</p></td><td><p><underline>Isovalerate</underline></p></td></tr><tr><td><p>Proline</p></td><td><p>Aliphatic</p></td><td><p><underline>Acetate</underline></p></td></tr><tr><td><p>Valine</p></td><td><p>Aliphatic</p></td><td><p><underline>Isobutyrate</underline></p></td></tr><tr><td><p>Asparagine</p></td><td><p>Amidic</p></td><td><p>Converted to aspartate</p></td></tr><tr><td><p>Glutamine</p></td><td><p>Amidic</p></td><td><p>Converted to glutamate</p></td></tr><tr><td><p>Phenylalanine</p></td><td><p>Aromatic</p></td><td><p>Phenolic SCFA</p><p>Phenylethylamine</p></td></tr><tr><td><p>Tryptophan</p></td><td><p>Aromatic</p></td><td><p>Indolic SCFA</p><p>Tryptamine</p></td></tr><tr><td><p>Tyrosine</p></td><td><p>Aromatic</p></td><td><p>4-Hydroxyphenolic SCFA</p><p>Tyramine</p></td></tr><tr><td><p>Arginine</p></td><td><p>Basic</p></td><td><p>Converted to other amino acids (mainly Ornithine)</p><p>Agmatine</p></td></tr><tr><td><p>Histidine</p></td><td><p>Basic</p></td><td><p><underline>Acetate</underline>, Butyrate</p><p>Histamine</p></td></tr><tr><td><p>Lysine</p></td><td><p>Basic</p></td><td><p><underline>Acetate</underline>, <underline>Butyrate</underline></p><p>Cadaverine</p></td></tr><tr><td><p>Serine</p></td><td><p>Hydroxylic</p></td><td><p><underline>Butyrate</underline></p></td></tr><tr><td><p>Threonine</p></td><td><p>Hydroxylic</p></td><td><p>Acetate, <underline>Propionate</underline>, Butyrate</p></td></tr><tr><td><p>Cysteine</p></td><td><p>Sulfur-containing</p></td><td><p><underline>Acetate</underline>, Butyrate, Hydrogen sulfide</p></td></tr><tr><td><p>Methionine</p></td><td><p>Sulfur-containing</p></td><td><p>Propionate, <underline>Butyrate</underline>, Methanethiol</p></td></tr></tbody></table><table-wrap-foot><p>Listed are the compounds found to be above 1 mM concentration in in vitro fermentation experiments conducted by Smith and Macfarlane [<xref ref-type="bibr" rid="CR92">92</xref>], in addition to the biogenic amines that can be produced by decarboxylation [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Underlined are the products indicated as most abundant as reported in a review article by Fan et al. [<xref ref-type="bibr" rid="CR12">12</xref>]</p></table-wrap-foot></table-wrap></p><sec id="Sec6"><title>Sulfur-containing amino acids</title><p id="Par20">Catabolism of the sulfur-containing amino acids, cysteine and methionine, results in the production of hydrogen sulfide and methanethiol, respectively [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], and a large number of taxonomically diverse bacterial species contain the requisite degradative enzymes within their genomes, including members of the Proteobacteria phylum, the Bacilli class, and the <italic>Clostridium</italic> and <italic>Bifidobacterium</italic> genera [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. Hydrogen sulfide can be methylated to methanethiol, which can be further methylated to dimethyl sulfide, and this methylation is thought to be part of the detoxification process due to the progressively less toxic nature of these compounds [<xref ref-type="bibr" rid="CR95">95</xref>]. However, methanethiol may also be converted to hydrogen sulfide, then oxidized to sulfate, for detoxification; this sulfate can then be utilized by sulfate-reducing bacteria [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR95">95</xref>]. Indeed, this latter reaction has been observed in cecal tissue, and is part of the sulfur cycle of the gut [<xref ref-type="bibr" rid="CR96">96</xref>]. The impact of hydrogen sulfide on host health has already been discussed, thus the focus will shift to the biogenic amines produced by basic amino acid fermentation and the phenol/indole compounds produced by aromatic amino acid fermentation.</p></sec><sec id="Sec7"><title>Basic amino acids</title><p id="Par21">A wide diversity of bacterial species within the gut microbiota can decarboxylate the basic amino acids, thus resulting in the formation of amine by-products shown in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>, including bifidobacteria, clostridia<italic>,</italic> lactobacilli, enterococci, streptococci, and members of the Enterobacteriaceae family [<xref ref-type="bibr" rid="CR97">97</xref>]<italic>.</italic> The catabolism of arginine can produce agmatine by deamination, and/or putrescine, spermidine, and spermine as part of the polyamine synthesis pathway (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). Agmatine inhibits the proliferation of IECs, which is thought to stem from its ability to reduce the synthesis and promote the degradation of other polyamines [<xref ref-type="bibr" rid="CR98">98</xref>]. This effect may not be negative depending on the context; for example, the resultant decrease of fatty acid metabolism in tissues reduced both weight gain and the hormonal derangements associated with obesity in rats fed a high fat chow [<xref ref-type="bibr" rid="CR99">99</xref>]. Agmatine also may be anti-inflammatory through inhibition of nitric oxide synthase [<xref ref-type="bibr" rid="CR100">100</xref>], and is a candidate neurotransmitter, with agonism for α<sub>2</sub>-adenoceptors and imidazoline binding sites, while simultaneously blocking ligand-gated cation channels (NMDA class) [<xref ref-type="bibr" rid="CR101">101</xref>]. The latter activity has therapeutic potential for remediating some forms of hyperalgesia and for its neuroprotectivity. Putrescine, on the other hand, is essential for the proliferation of IECs [<xref ref-type="bibr" rid="CR102">102</xref>]. It is the precursor to spermidine/spermine, which are both able to relieve oxidative stress and promote cellular longevity through autophagy stimulation [<xref ref-type="bibr" rid="CR103">103</xref>]. All three polyamines improve the integrity of the gut by increasing expression of tight junction proteins [<xref ref-type="bibr" rid="CR104">104</xref>], promoting intestinal restitution [<xref ref-type="bibr" rid="CR105">105</xref>] and increasing mucus secretion [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. Finally, both putrescine and spermine are able to inhibit the production of pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-α [<xref ref-type="bibr" rid="CR107">107</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. Therefore, any benefits of agmatine must be weighed against its consequent reduction of these polyamines; it may be effective in the treatment of certain conditions such as metabolic syndrome but could be detrimental in excess under normal conditions. Arginine can additionally be converted to glutamate, which can be deaminated to produce 4-aminobutryate (GABA). GABA is the major inhibitory neurotransmitter of the central nervous system, and alterations in the expression of its receptor have been linked to the pathogenesis of depression and anxiety [<xref ref-type="bibr" rid="CR109">109</xref>]. Administration of lactobacilli and bifidobacteria that produce GABA to mice and rats has resulted in a decrease of depressive behaviors, a reduction of corticosterone induced stress and anxiety, and lessened visceral pain sensation [<xref ref-type="bibr" rid="CR109">109</xref>–<xref ref-type="bibr" rid="CR111">111</xref>]. GABA can additionally regulate the proliferation of T cells and thus has immunomodulatory properties [<xref ref-type="bibr" rid="CR112">112</xref>]. Interestingly, chronic GI inflammation not only induces anxiety in mice, but depression and anxiety often present comorbidity with GI disorders, including irritable bowel syndrome (IBS) [<xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR113">113</xref>].</p><p id="Par22">The catabolism of histidine can produce histamine (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). Histamine may be synonymous with its exertion of inflammation in allergic responses, but bacterially produced histamine has actually been shown to inhibit the production of the pro-inflammatory cytokines TNF-α in vivo [<xref ref-type="bibr" rid="CR114">114</xref>], and IL-1, and IL-12 in vitro [<xref ref-type="bibr" rid="CR115">115</xref>], while simultaneously preventing intestinal bacterial translocation. Histamine is also a neurotransmitter, modulating several processes such as wakefulness, motor control, dendritic cell activity, pain perception, and learning and memory [<xref ref-type="bibr" rid="CR116">116</xref>]. Low levels of histamine are associated with Alzheimer’s disease, convulsions, and seizures, and increasing its concentration has antinociceptive properties [<xref ref-type="bibr" rid="CR117">117</xref>]. However, there is likely a range of suitable concentration, as high levels of histamine are associated with sleep disorders, Parkinson’s disease, schizophrenia, and autism [<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR117">117</xref>].</p><p id="Par23">The catabolism of lysine can produce cadaverine (Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>). Cadaverine is a poorly studied metabolite; it can be toxic, but only in high amounts [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. Cadaverine has, however, been shown to potentiate histamine toxicity [<xref ref-type="bibr" rid="CR118">118</xref>] and higher concentrations of cadaverine are associated with ulcerative colitis (UC) [<xref ref-type="bibr" rid="CR119">119</xref>].</p></sec><sec id="Sec8"><title>Aromatic amino acids</title><p id="Par24">Aromatic amino acid degradation can yield a wide diversity of indolic and phenolic compounds that can act as toxins or neurotransmitters as shown in Additional file <xref ref-type="supplementary-material" rid="MOESM2">2</xref>. The catabolism of tryptophan can produce tryptamine and indoles (Additional file <xref ref-type="supplementary-material" rid="MOESM2">2</xref>). Tryptamine is a neurotransmitter that plays a role in regulating intestinal motility and immune function [<xref ref-type="bibr" rid="CR120">120</xref>]. Particularly, it is able to interact with both indoleamine 2,3-dioxygenase and the aryl hydrocarbon receptor to heighten immune surveillance, and dampen the expression of pro-inflammatory cytokines, respectively [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]. A lack of these activities has therefore been implicated in the pathology of IBD; although, it should be noted that most tryptophan metabolites can interact with these receptors, thus it is not tryptamine-specific [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR122">122</xref>]. Tryptamine can also both potentiate the inhibitory response of cells to serotonin and induce its release from enteroendocrine cells [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR123">123</xref>]. Serotonin is a neurotransmitter involved in many processes including mood, appetite, hemostasis, immunity, and bone development [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR124">124</xref>]. Its dysregulation is thus reported in many disorders, including IBD [<xref ref-type="bibr" rid="CR125">125</xref>], IBS [<xref ref-type="bibr" rid="CR126">126</xref>], cardiovascular disease [<xref ref-type="bibr" rid="CR127">127</xref>], and osteoporosis [<xref ref-type="bibr" rid="CR128">128</xref>]. Tryptophan decarboxylation is a rare activity among species of the gut microbiota, but certain Firmicutes have been found to be capable of it, including the IBD-associated species, <italic>Ruminococcus gnavus</italic> [<xref ref-type="bibr" rid="CR129">129</xref>, <xref ref-type="bibr" rid="CR130">130</xref>]<italic>.</italic> Indole, on the other hand, is a major bacterial metabolite of tryptophan, produced by many species of <italic>Bacteroides</italic> and Enterobacteriaceae [<xref ref-type="bibr" rid="CR120">120</xref>]<italic>.</italic> It plays an important role in host defense, by interacting with the pregnane X receptor and the aryl hydrocarbon receptor [<xref ref-type="bibr" rid="CR120">120</xref>]. This activity fortifies the intestinal barrier by increasing tight junction protein expression and downregulates the expression of pro-inflammatory cytokines [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR131">131</xref>]. It also induces glucagon like peptide-1 (an incretin) secretion by enteroendocrine cells, inhibiting gastric secretion and motility, to promote satiety [<xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]. Indole is additionally a signaling molecule for bacteria, influencing motility, biofilm formation, antibiotic resistance, and virulence, and shown to inhibit the colonization capabilities of pathogens such as <italic>Salmonella enterica</italic> [<xref ref-type="bibr" rid="CR134">134</xref>]. However, indole overproduction can increase its export to the liver, where it is sulfated to indoxyl sulfate, a uremic toxin associated with chronic kidney disease [<xref ref-type="bibr" rid="CR135">135</xref>]. Further, its effects as a signaling molecule for both enteroendocrine cells and bacteria are dose dependent, with high concentrations rendering it ineffective [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR134">134</xref>]. Other indole metabolites are additionally able to interact with the pregnane X receptor and/or aryl hydrocarbon receptor in a similar fashion, thus benefiting the host, but are less well studied [<xref ref-type="bibr" rid="CR120">120</xref>].</p><p id="Par25">The catabolism of tyrosine can produce tyramine, phenols, and p-coumarate (Additional file <xref ref-type="supplementary-material" rid="MOESM2">2</xref>). Tyramine is a neurotransmitter that can be produced by certain gut bacteria via decarboxylation, including <italic>Enterococcus</italic> and Enterobacteriaceae [<xref ref-type="bibr" rid="CR97">97</xref>]. It is infamous for causing the ‘cheese reaction’ hypertensive crisis in individuals taking monoamine inhibitor class drugs, although it can additionally cause migraines and hypertension in sensitive individuals or a mild rise in blood pressure when consumed in excess by the general populace [<xref ref-type="bibr" rid="CR136">136</xref>]. Tyramine facilitates the release of norepinephrine that induces peripheral vasoconstriction, elevates blood glucose levels, and increases cardiac output and respiration [<xref ref-type="bibr" rid="CR137">137</xref>]. It has also been shown to increase the synthesis of serotonin by enteroendocrine cells in the gut, elevating its release into circulation [<xref ref-type="bibr" rid="CR124">124</xref>]. Phenol and p-cresol are phenolic metabolites that have been shown to both decrease the integrity of the gut epithelium and the viability of IECs [<xref ref-type="bibr" rid="CR138">138</xref>, <xref ref-type="bibr" rid="CR139">139</xref>], and can be produced by many gut bacterial species, such as members of the Enterobacteriaceae and <italic>Clostridium</italic> clusters I, XI, and XIVa [<xref ref-type="bibr" rid="CR140">140</xref>]. P-cresol in particular is genotoxic, elevates the production of superoxide, and inhibits proliferation of IECs [<xref ref-type="bibr" rid="CR141">141</xref>]. P-cresol may additionally be sulfated to cresyl sulfate in the gut or liver, which has been found to suppress the T helper 1-mediated immune response in mice [<xref ref-type="bibr" rid="CR142">142</xref>], and, interestingly, phenolic sulfation was found to be impaired in the gut mucosa of UC patients [<xref ref-type="bibr" rid="CR143">143</xref>]. Indeed, the colonic damage induced by unconjugated phenols is similar to that observed in IBD [<xref ref-type="bibr" rid="CR138">138</xref>]. Cresyl sulfate is also associated with chronic kidney disease, however, as it can damage renal tubular cells through induction of oxidative stress [<xref ref-type="bibr" rid="CR144">144</xref>]. This compound is also particularly elevated in the urine of autistic patients, but a causative link in this case has not been elucidated [<xref ref-type="bibr" rid="CR145">145</xref>].</p><p id="Par26">The catabolism of phenylalanine can produce phenylethylamine and trans-cinnamic acid (Additional file <xref ref-type="supplementary-material" rid="MOESM2">2</xref>). Unlike tyrosine and tryptophan, little is known about these phenylalanine-derived metabolites. Phenylethylamine is a neurotransmitter that functions as an ‘endogenous amphetamine’ yielded from decarboxylation [<xref ref-type="bibr" rid="CR136">136</xref>]. Through facilitating the release of catecholamine and serotonin, phenylethylamine in turn elevates mood, energy, and attention [<xref ref-type="bibr" rid="CR146">146</xref>]. However, it has been reported that ingesting phenylethylamine can induce headache, dizziness, and discomfort in individuals with a reduced ability to convert it to phenylacetate, suggesting excessive amounts have negative consequences [<xref ref-type="bibr" rid="CR136">136</xref>]. In terms of its production in the gut, phenylethylamine has thus been positively associated with Crohn’s disease and negatively correlated with <italic>Faecalibacterium prausnitzii</italic> in one study [<xref ref-type="bibr" rid="CR147">147</xref>]. The conversion of phenylalanine to trans-cinnamate and tyrosine to p-coumaric acid results in increased phenylpropionate and 4-hydroxyphenylpropionate concentrations, which in turn produce urinary metabolites associated with the ‘chlorogenic acid’ phenotype in rats, as suggested by Clayton [<xref ref-type="bibr" rid="CR148">148</xref>]. These metabolic pathways were found to so far specifically occur within species of <italic>Clostridium</italic> and <italic>Peptostreptococcus</italic>, respectively [<xref ref-type="bibr" rid="CR149">149</xref>, <xref ref-type="bibr" rid="CR150">150</xref>]. The chlorogenic acid phenotype is associated with both autism and schizophrenia, suggesting a role of altered aromatic amino acid metabolism in these disorders [<xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR151">151</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. However, further research is still needed, as there remains no mechanistic explanation of these metabolites toward disease development. Further, both trans-cinnamic acid and p-coumaric acid are negatively associated with cardiovascular disease [<xref ref-type="bibr" rid="CR153">153</xref>, <xref ref-type="bibr" rid="CR154">154</xref>]. P-coumaric acid, in particular, is a common phenolic compound derived from plant matter that has anti-inflammatory properties, and has been demonstrated to prevent platelet aggregation [<xref ref-type="bibr" rid="CR155">155</xref>]. Thus, these metabolites may simply be an indicator of altered microbial metabolism in general, when found in excess.</p></sec></sec><sec id="Sec9"><title>Catabolism of lipids</title><p id="Par27">A very small proportion of total dietary fat reaches the colon (&lt; 5%) [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR156">156</xref>]. Microorganisms in the gut are known to possess lipases, which can degrade triglycerides and phospholipids into their polar head groups and free lipids [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR157">157</xref>]. Triglycerides represent 95% of total dietary fat, whereas phospholipids, mostly in the form of phosphotidylcholine, constitute a minor portion, but are also derived endogenously from bile acids [<xref ref-type="bibr" rid="CR158">158</xref>]. Certain bacteria inhabiting the GI tract, including species of lactobacilli, enterococci, clostridia, and Proteobacteria, can utilize the backbone of triglycerides as an electron sink, reducing glycerol to 1,3-propanediol [<xref ref-type="bibr" rid="CR159">159</xref>]. 3-Hydroxypropanal (reuterin) is an intermediate of this process that has been reported to accumulate extracellularly in cultures of <italic>Lactobacillus</italic> and <italic>Enterococcus</italic> spp<italic>.</italic> [<xref ref-type="bibr" rid="CR160">160</xref>]<italic>.</italic> Reuterin has antimicrobial properties acting against pathogens and commensals alike [<xref ref-type="bibr" rid="CR161">161</xref>], but it can also be spontaneously dehydrated to acrolein [<xref ref-type="bibr" rid="CR71">71</xref>]. Acrolein is a highly reactive genotoxin, with an equivalent mutagenic potency to formaldehyde, raising concerns about this metabolic process [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR159">159</xref>]. Meanwhile, choline can additionally be metabolized to trimethylamine by species of the gut microbiota, particularly Clostridia (especially members of <italic>Clostridium</italic> cluster XIVa and <italic>Eubacterium</italic> spp<italic>.</italic>) and Proteobacteria [<xref ref-type="bibr" rid="CR162">162</xref>, <xref ref-type="bibr" rid="CR163">163</xref>]. Trimethylamine is oxidized in the liver to trimethylamine N-oxide [<xref ref-type="bibr" rid="CR163">163</xref>, <xref ref-type="bibr" rid="CR164">164</xref>], which exacerbates atherosclerosis by promoting the formation of foam cells (lipid-laden macrophages) [<xref ref-type="bibr" rid="CR164">164</xref>] and altering cholesterol transport [<xref ref-type="bibr" rid="CR165">165</xref>]. High levels of serum trimethylamine N-oxide are thus associated with cardiovascular disease [<xref ref-type="bibr" rid="CR166">166</xref>] and atherosclerosis [<xref ref-type="bibr" rid="CR167">167</xref>]. However, it should be noted that active research in these areas is in its early stages, and thus the link between the gut microbiota-mediated lipid head group metabolism and health consequences is still unclear. For example, a study on the metabolism of glycerol by fecal microbial communities found that only a subset could reduce it to 1,3-propanediol, and the authors did not detect any reuterin [<xref ref-type="bibr" rid="CR159">159</xref>]. Further, some members of the gut microbiota (e.g., methylotrophs) can breakdown trimethylamine to dimethylamine, so the actual amount of trimethylamine that is available for transportation to the liver can be diverted, and this is likely to be influenced by inter-individual variability in the composition of the gut microbiota [<xref ref-type="bibr" rid="CR168">168</xref>].</p><p id="Par28">In contrast to the polar head groups, microorganisms are not thought to have the ability to catabolize free lipids in the anaerobic environment of the gut [<xref ref-type="bibr" rid="CR169">169</xref>]. However, free lipids have antimicrobial properties [<xref ref-type="bibr" rid="CR169">169</xref>, <xref ref-type="bibr" rid="CR170">170</xref>] and can directly interact with host pattern recognition receptors. Particularly, saturated fatty acids are TLR4 agonists that promote inflammation [<xref ref-type="bibr" rid="CR171">171</xref>], whereas omega-3 unsaturated fatty acids are TLR4 antagonists that prevent inflammation [<xref ref-type="bibr" rid="CR172">172</xref>]. Interestingly, chronic inflammation co-occurring with obesity has been well described [<xref ref-type="bibr" rid="CR173">173</xref>], and could be a result of the aforementioned pro-inflammatory properties of free lipids, the lack of anti-inflammatory SCFAs produced from carbohydrate fermentation (high-fat diets tend to be low in carbohydrates), or a combination of both. High-fat diets do have a reported impact on the composition of the gut microbiota, yet it is unclear whether it is the increased fat content per se or the relative decrease in carbohydrates, which often accompanies these diets, that is the chief influencer [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR169">169</xref>]. Indeed, Morales et al. observed that a high-fat diet including fiber supplementation induces inflammation without altering the composition of the gut microbiota [<xref ref-type="bibr" rid="CR16">16</xref>]. Regardless, the gut microbiota is required for the development of obesity, as shown in GF mice experiments, because of the ability of SCFAs to alter energy balance as previously discussed [<xref ref-type="bibr" rid="CR174">174</xref>].</p></sec><sec id="Sec10"><title>Effect on endogenous substrate utilization</title><p id="Par29">Metabolism of exogenous substrates greatly affects the use of endogenous substrates by the gut microbiota. Dietary fiber reduces the degradation of mucin, and the utilization of mucin is thought to cycle daily depending on the availability of food sources [<xref ref-type="bibr" rid="CR175">175</xref>, <xref ref-type="bibr" rid="CR176">176</xref>]. Mucin is a sulfated glycoprotein [<xref ref-type="bibr" rid="CR38">38</xref>], thus the same concepts of carbohydrate and protein degradation from dietary sources discussed above apply. However, it should be noted that mucin turnover by the gut microbiota is a naturally occurring process, and only when it occurs in elevated amounts does it have negative connotations. For example, <italic>Akkermansia muciniphila</italic> is a mucin-utilizing specialist that is depleted in the GI tract of IBD [<xref ref-type="bibr" rid="CR177">177</xref>] and metabolic syndrome [<xref ref-type="bibr" rid="CR178">178</xref>] patients. <italic>A</italic>. <italic>muciniphila</italic> has a demonstrated ability to cross-talk with host cells, promoting an increase in concentration of glucagon-like peptides, 2-arabinoglycerol, and antimicrobial peptides that improve barrier function, reduce inflammation, and induce proliferation of IECs [<xref ref-type="bibr" rid="CR179">179</xref>]. Through this communication, <italic>A</italic>. <italic>muciniphila</italic> also, paradoxically, restored the thickness of the mucin layer in obese mice. Dietary fat intake can also alter the profile of bile acids. Dairy-derived saturated lipids increase the relative amount of taurine-conjugation, and this sulfur-containing compound leads to the expansion of sulfate-reducing bacteria in the gut [<xref ref-type="bibr" rid="CR180">180</xref>]. Bile acid turnover is, however, a naturally occurring process, which modulates bile acid reabsorption, inflammation, triglyceride control, and glucose homeostasis from IEC signaling [<xref ref-type="bibr" rid="CR181">181</xref>].</p></sec><sec id="Sec11" sec-type="conclusions"><title>Conclusions</title><p id="Par30">The critical contributions of the gut microbiota toward human digestion have just begun to be elucidated. Particularly, more recent research is revealing how the impacts of microbial metabolism extend beyond the GI tract, denoting the so-called gut-brain (e.g., biogenic amines acting as neurotransmitters) [<xref ref-type="bibr" rid="CR182">182</xref>], gut-liver (e.g., alcohols) [<xref ref-type="bibr" rid="CR183">183</xref>], gut-kidney (e.g., uremic toxins such as cresyl sulfate) [<xref ref-type="bibr" rid="CR135">135</xref>], and gut-heart (e.g., trimethylamine) [<xref ref-type="bibr" rid="CR184">184</xref>] axes. The primary focus to date has been on the SCFAs derived mainly from complex carbohydrates, and crucial knowledge gaps still remain in this area, specifically on how the SCFAs modulate glucose metabolism and fat deposition upon reaching the liver. However, the degradation of proteins and fats are comparatively less well understood. Due to both the diversity of metabolites that can be yielded and the complexity of microbial pathways, which can act as a self-regulating system that removes toxic by-products, it is not merely a matter of such processes effecting health positively or negatively, but rather how they are balanced. Further, the presentation of these substrates to the gut microbiota, as influenced by the relatively understudied host digestive processes occurring in the small intestine, is equally important. Future work could therefore aim to determine which of these pathways are upregulated and downregulated in disease states, such as autism and depression (gut-brain), NAFLD (gut-liver), chronic kidney disease (gut-kidney), and cardiovascular disease (gut-heart). Further, a combination of human- and culture- (in vitro and in vivo) based studies could resolve the spectrum of protein and fat degradation present among healthy individuals, in order to further our understanding of nutrient cycling in gut microbial ecosystems, and thus gain a necessary perspective for improving wellness.</p></sec></body><back><ack><title>Acknowledgements</title><sec><p>Not applicable.</p></sec><sec id="FPar1"><title>Funding</title><p id="Par31">We would like to acknowledge the National Science and Research Council of Canada scholarship and Ontario Ministry of Training, Colleges and Universities scholarship to KO for providing funding.</p></sec><sec id="FPar2"><title>Availability of data and materials</title><p id="Par32">Not applicable.</p></sec></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>KO researched and wrote the manuscript. EA-V oversaw editing of the final version of the manuscript. All authors approved the final manuscript.</p></sec><sec sec-type="ethics-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par33">Not applicable.</p></sec><sec id="FPar4"><title>Consent for publication</title><p id="Par34">Not applicable.</p></sec><sec id="FPar5" sec-type="COI-statement"><title>Competing interests</title><p id="Par35">EA-V is the co-founder and CSO of NuBiyota LLC, a company which is working to commercialize human gut-derived microbial communities for use in medical indications.</p></sec><sec id="FPar6"><title>Publisher’s Note</title><p id="Par36">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thursby</surname><given-names>E</given-names></name><name><surname>Juge</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Introduction to the human gut microbiota</article-title><source>Biochem J</source><year>2017</year><volume>474</volume><fpage>1823</fpage><lpage>1836</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXptFenurY%3D</pub-id><pub-id pub-id-type="pmid">28512250</pub-id><pub-id pub-id-type="pmcid">5433529</pub-id><pub-id pub-id-type="doi">10.1042/BCJ20160510</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Cai</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Sunagawa</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">An integrated catalog of reference genes in the human gut microbiome</article-title><source>Nat Biotechnol</source><year>2014</year><volume>32</volume><fpage>834</fpage><lpage>841</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtFSlsLjP</pub-id><pub-id pub-id-type="doi">10.1038/nbt.2942</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turnbaugh</surname><given-names>PJ</given-names></name><name><surname>Ley</surname><given-names>RE</given-names></name><name><surname>Hamady</surname><given-names>M</given-names></name><name><surname>Fraser-Liggett</surname><given-names>C</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title xml:lang="en">The human microbiome project: exploring the microbial part of ourselves in a changing world</article-title><source>Nature</source><year>2007</year><volume>449</volume><fpage>804</fpage><lpage>810</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtFOjt7nP</pub-id><pub-id pub-id-type="pmid">17943116</pub-id><pub-id pub-id-type="pmcid">3709439</pub-id><pub-id pub-id-type="doi">10.1038/nature06244</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Human Microbiome Project Consortium</collab></person-group><article-title xml:lang="en">Structure, function and diversity of the healthy human microbiome</article-title><source>Nature</source><year>2012</year><volume>486</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1038/nature11234</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xos1ejurs%3D</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belkaid</surname><given-names>Y</given-names></name><name><surname>Hand</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Role of the microbiota in immunity and inflammation</article-title><source>Cell</source><year>2014</year><volume>157</volume><fpage>121</fpage><lpage>141</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXmtVCqsL8%3D</pub-id><pub-id pub-id-type="pmid">24679531</pub-id><pub-id pub-id-type="pmcid">4056765</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2014.03.011</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiljar</surname><given-names>M</given-names></name><name><surname>Merkler</surname><given-names>D</given-names></name><name><surname>Trajkovski</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">The immune system bridges the gut microbiota with systemic energy homeostasis: focus on TLRs, mucosal barrier, and SCFAs</article-title><source>Front Immunol</source><year>2017</year><volume>8</volume><fpage>1353</fpage><pub-id pub-id-type="pmid">29163467</pub-id><pub-id pub-id-type="pmcid">5670327</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2017.01353</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitFegu7nJ</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillman</surname><given-names>ET</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Yao</surname><given-names>T</given-names></name><name><surname>Nakatsu</surname><given-names>CH</given-names></name></person-group><article-title xml:lang="en">Microbial ecology along the gastrointestinal tract</article-title><source>Microbes Environ</source><year>2017</year><volume>32</volume><fpage>300</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">29129876</pub-id><pub-id pub-id-type="pmcid">5745014</pub-id><pub-id pub-id-type="doi">10.1264/jsme2.ME17017</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Guryn</surname><given-names>K</given-names></name><name><surname>Hubert</surname><given-names>N</given-names></name><name><surname>Frazier</surname><given-names>K</given-names></name><name><surname>Urlass</surname><given-names>S</given-names></name><name><surname>Musch</surname><given-names>MW</given-names></name><name><surname>Ojeda</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">Small intestine microbiota regulate host digestive and absorptive adaptive responses to dietary lipids</article-title><source>Cell Host Microbe</source><year>2018</year><volume>23</volume><fpage>458</fpage><lpage>469</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXnsFCnsrY%3D</pub-id><pub-id pub-id-type="pmid">29649441</pub-id><pub-id pub-id-type="pmcid">5912695</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2018.03.011</pub-id><comment>e5</comment></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>F</given-names></name><name><surname>Anderson</surname><given-names>JM</given-names></name><name><surname>Bharti</surname><given-names>R</given-names></name><name><surname>Raes</surname><given-names>J</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">The resilience of the intestinal microbiota influences health and disease</article-title><source>Nat Rev Microbiol</source><year>2017</year><volume>15</volume><fpage>630</fpage><lpage>638</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtVWis7zO</pub-id><pub-id pub-id-type="pmid">28626231</pub-id><pub-id pub-id-type="doi">10.1038/nrmicro.2017.58</pub-id><pub-id pub-id-type="pmcid">28626231</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theriot</surname><given-names>CM</given-names></name><name><surname>Young</surname><given-names>VB</given-names></name></person-group><article-title xml:lang="en">Interactions between the gastrointestinal microbiome and <italic>Clostridium difficile</italic></article-title><source>Annu Rev Microbiol</source><year>2015</year><volume>69</volume><fpage>445</fpage><lpage>461</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhslSru7vO</pub-id><pub-id pub-id-type="pmid">4892173</pub-id><pub-id pub-id-type="pmcid">4892173</pub-id><pub-id pub-id-type="doi">10.1146/annurev-micro-091014-104115</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stecher</surname><given-names>B</given-names></name><name><surname>Hardt</surname><given-names>W-D</given-names></name></person-group><article-title xml:lang="en">Mechanisms controlling pathogen colonization of the gut</article-title><source>Curr Opin Microbiol</source><year>2011</year><volume>14</volume><fpage>82</fpage><lpage>91</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhvV2qt7g%3D</pub-id><pub-id pub-id-type="pmid">21036098</pub-id><pub-id pub-id-type="doi">10.1016/j.mib.2010.10.003</pub-id><pub-id pub-id-type="pmcid">21036098</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Rezaei</surname><given-names>A</given-names></name><name><surname>Eslamfam</surname><given-names>S</given-names></name><name><surname>Che</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name></person-group><article-title xml:lang="en">Metabolites of dietary protein and peptides by intestinal microbes and their impacts on gut</article-title><source>Curr Protein Pept Sci</source><year>2015</year><volume>16</volume><fpage>646</fpage><lpage>654</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhsFWms7jM</pub-id><pub-id pub-id-type="pmid">26122784</pub-id><pub-id pub-id-type="doi">10.2174/1389203716666150630133657</pub-id><pub-id pub-id-type="pmcid">26122784</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portune</surname><given-names>KJ</given-names></name><name><surname>Beaumont</surname><given-names>M</given-names></name><name><surname>Davila</surname><given-names>A-M</given-names></name><name><surname>Tomé</surname><given-names>D</given-names></name><name><surname>Blachier</surname><given-names>F</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Gut microbiota role in dietary protein metabolism and health-related outcomes: the two sides of the coin</article-title><source>Trends Food Sci Technol</source><year>2016</year><volume>57</volume><fpage>213</fpage><lpage>232</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsVakt73N</pub-id><pub-id pub-id-type="doi">10.1016/j.tifs.2016.08.011</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>CK</given-names></name><name><surname>Muir</surname><given-names>JG</given-names></name><name><surname>Gibson</surname><given-names>PR</given-names></name></person-group><article-title xml:lang="en">Review article: insights into colonic protein fermentation, its modulation and potential health implications</article-title><source>Aliment Pharmacol Ther</source><year>2016</year><volume>43</volume><fpage>181</fpage><lpage>196</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXitVentLzJ</pub-id><pub-id pub-id-type="pmid">26527169</pub-id><pub-id pub-id-type="doi">10.1111/apt.13456</pub-id><pub-id pub-id-type="pmcid">26527169</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajmalnik-Brown</surname><given-names>R</given-names></name><name><surname>Ilhan</surname><given-names>Z-E</given-names></name><name><surname>Kang</surname><given-names>D-W</given-names></name><name><surname>DiBaise</surname><given-names>JK</given-names></name></person-group><article-title xml:lang="en">Effects of gut microbes on nutrient absorption and energy regulation</article-title><source>Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr</source><year>2012</year><volume>27</volume><fpage>201</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1177/0884533611436116</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morales</surname><given-names>P</given-names></name><name><surname>Fujio</surname><given-names>S</given-names></name><name><surname>Navarrete</surname><given-names>P</given-names></name><name><surname>Ugalde</surname><given-names>JA</given-names></name><name><surname>Magne</surname><given-names>F</given-names></name><name><surname>Carrasco-Pozo</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Impact of dietary lipids on colonic function and microbiota: an experimental approach involving orlistat-induced fat malabsorption in human volunteers</article-title><source>Clin Transl Gastroenterol</source><year>2016</year><volume>7</volume><fpage>e161</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xmt1ejs7Y%3D</pub-id><pub-id pub-id-type="pmid">27054579</pub-id><pub-id pub-id-type="pmcid">4855161</pub-id><pub-id pub-id-type="doi">10.1038/ctg.2016.20</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>JMW</given-names></name><name><surname>Jenkins</surname><given-names>DJA</given-names></name></person-group><article-title xml:lang="en">Carbohydrate digestibility and metabolic effects</article-title><source>J Nutr</source><year>2007</year><volume>137</volume><fpage>2539S</fpage><lpage>2546S</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXht1ynsbjN</pub-id><pub-id pub-id-type="pmid">17951499</pub-id><pub-id pub-id-type="doi">10.1093/jn/137.11.2539S</pub-id><pub-id pub-id-type="pmcid">17951499</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roager</surname><given-names>HM</given-names></name><name><surname>Hansen</surname><given-names>LBS</given-names></name><name><surname>Bahl</surname><given-names>MI</given-names></name><name><surname>Frandsen</surname><given-names>HL</given-names></name><name><surname>Carvalho</surname><given-names>V</given-names></name><name><surname>Gøbel</surname><given-names>RJ</given-names></name><etal/></person-group><article-title xml:lang="en">Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut</article-title><source>Nat Microbiol</source><year>2016</year><volume>1</volume><fpage>16093</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXkvFyrs7g%3D</pub-id><pub-id pub-id-type="pmid">27562254</pub-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.93</pub-id><pub-id pub-id-type="pmcid">27562254</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degen</surname><given-names>LP</given-names></name><name><surname>Phillips</surname><given-names>SF</given-names></name></person-group><article-title xml:lang="en">Variability of gastrointestinal transit in healthy women and men</article-title><source>Gut</source><year>1996</year><volume>39</volume><fpage>299</fpage><lpage>305</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK2s7jtFyrsQ%3D%3D</pub-id><pub-id pub-id-type="pmid">8977347</pub-id><pub-id pub-id-type="pmcid">1383315</pub-id><pub-id pub-id-type="doi">10.1136/gut.39.2.299</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biesalski</surname><given-names>HK</given-names></name></person-group><article-title xml:lang="en">Nutrition meets the microbiome: micronutrients and the microbiota</article-title><source>Ann N Y Acad Sci</source><year>2016</year><volume>1372</volume><fpage>53</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">27362360</pub-id><pub-id pub-id-type="doi">10.1111/nyas.13145</pub-id><pub-id pub-id-type="pmcid">27362360</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozdal</surname><given-names>T</given-names></name><name><surname>Sela</surname><given-names>DA</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Boyacioglu</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Capanoglu</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility</article-title><source>Nutrients</source><year>2016</year><volume>8</volume><fpage>78</fpage><pub-id pub-id-type="pmid">26861391</pub-id><pub-id pub-id-type="pmcid">4772042</pub-id><pub-id pub-id-type="doi">10.3390/nu8020078</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XitFSktrjO</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>T</given-names></name><name><surname>Ghosh</surname><given-names>TS</given-names></name><name><surname>Mande</surname><given-names>SS</given-names></name></person-group><article-title xml:lang="en">Global profiling of carbohydrate active enzymes in human gut microbiome</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0142038</fpage><pub-id pub-id-type="pmid">26544883</pub-id><pub-id pub-id-type="pmcid">4636310</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0142038</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhvFKnurnL</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Bjursell</surname><given-names>MK</given-names></name><name><surname>Himrod</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>S</given-names></name><name><surname>Carmichael</surname><given-names>LK</given-names></name><name><surname>Chiang</surname><given-names>HC</given-names></name><etal/></person-group><article-title xml:lang="en">A genomic view of the human-<italic>Bacteroides thetaiotaomicron</italic> symbiosis</article-title><source>Science</source><year>2003</year><volume>299</volume><fpage>2074</fpage><lpage>2076</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXitlCisL0%3D</pub-id><pub-id pub-id-type="pmid">12663928</pub-id><pub-id pub-id-type="doi">10.1126/science.1080029</pub-id><pub-id pub-id-type="pmcid">12663928</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Chang</surname><given-names>H-W</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Ucmak</surname><given-names>D</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Influence of diet on the gut microbiome and implications for human health</article-title><source>J Transl Med</source><year>2017</year><volume>15</volume><fpage>73</fpage><pub-id pub-id-type="pmid">5385025</pub-id><pub-id pub-id-type="pmcid">5385025</pub-id><pub-id pub-id-type="doi">10.1186/s12967-017-1175-y</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsVans7%2FO</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="other">Wolfe AJ. Glycolysis for the microbiome generation. Microbiol Spectr. 2015;3 <ext-link xlink:href="https://doi.org/10.1128/microbiolspec.MBP-0014-2014" ext-link-type="doi">https://doi.org/10.1128/microbiolspec.MBP-0014-2014</ext-link>.</mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vergnolle</surname><given-names>Nathalie</given-names></name></person-group><article-title xml:lang="en">Protease inhibition as new therapeutic strategy for GI diseases</article-title><source>Gut</source><year>2016</year><volume>65</volume><issue>7</issue><fpage>1215</fpage><lpage>1224</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhslaitr7K</pub-id><pub-id pub-id-type="pmid">27196587</pub-id><pub-id pub-id-type="pmcid">4941139</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2015-309147</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Piao</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">A review of the relationship between the gut microbiota and amino acid metabolism</article-title><source>Amino Acids</source><year>2017</year><volume>49</volume><fpage>2083</fpage><lpage>2090</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhsFehtbvL</pub-id><pub-id pub-id-type="pmid">28932911</pub-id><pub-id pub-id-type="doi">10.1007/s00726-017-2493-3</pub-id><pub-id pub-id-type="pmcid">28932911</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>EA</given-names></name><name><surname>Macfarlane</surname><given-names>GT</given-names></name></person-group><article-title xml:lang="en">Enumeration of amino acid fermenting bacteria in the human large intestine: effects of pH and starch on peptide metabolism and dissimilation of amino acids</article-title><source>FEMS Microbiol Ecol</source><year>1998</year><volume>25</volume><fpage>355</fpage><lpage>368</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXitlSrsrk%3D</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-6941.1998.tb00487.x</pub-id></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geboes</surname><given-names>KP</given-names></name><name><surname>De Hertogh</surname><given-names>G</given-names></name><name><surname>De Preter</surname><given-names>V</given-names></name><name><surname>Luypaerts</surname><given-names>A</given-names></name><name><surname>Bammens</surname><given-names>B</given-names></name><name><surname>Evenepoel</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">The influence of inulin on the absorption of nitrogen and the production of metabolites of protein fermentation in the colon</article-title><source>Br J Nutr</source><year>2006</year><volume>96</volume><fpage>1078</fpage><lpage>1086</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtFCqtr4%3D</pub-id><pub-id pub-id-type="pmid">17181883</pub-id><pub-id pub-id-type="doi">10.1017/BJN20061936</pub-id><pub-id pub-id-type="pmcid">17181883</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donohoe</surname><given-names>DR</given-names></name><name><surname>Garge</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>W</given-names></name><name><surname>O’Connell</surname><given-names>TM</given-names></name><name><surname>Bunger</surname><given-names>MK</given-names></name><etal/></person-group><article-title xml:lang="en">The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon</article-title><source>Cell Metab</source><year>2011</year><volume>13</volume><fpage>517</fpage><lpage>526</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXlsFalsro%3D</pub-id><pub-id pub-id-type="pmid">21531334</pub-id><pub-id pub-id-type="pmcid">3099420</pub-id><pub-id pub-id-type="doi">10.1016/j.cmet.2011.02.018</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falony</surname><given-names>G</given-names></name><name><surname>Joossens</surname><given-names>M</given-names></name><name><surname>Vieira-Silva</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Darzi</surname><given-names>Y</given-names></name><name><surname>Faust</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Population-level analysis of gut microbiome variation</article-title><source>Science</source><year>2016</year><volume>352</volume><fpage>560</fpage><lpage>564</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xms1Kisbo%3D</pub-id><pub-id pub-id-type="pmid">27126039</pub-id><pub-id pub-id-type="doi">10.1126/science.aad3503</pub-id><pub-id pub-id-type="pmcid">27126039</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd-Price</surname><given-names>J</given-names></name><name><surname>Abu-Ali</surname><given-names>G</given-names></name><name><surname>Huttenhower</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">The healthy human microbiome</article-title><source>Genome Med</source><year>2016</year><volume>8</volume><fpage>51</fpage><pub-id pub-id-type="pmid">27122046</pub-id><pub-id pub-id-type="pmcid">4848870</pub-id><pub-id pub-id-type="doi">10.1186/s13073-016-0307-y</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>A</given-names></name><name><surname>De Vadder</surname><given-names>F</given-names></name><name><surname>Kovatcheva-Datchary</surname><given-names>P</given-names></name><name><surname>Bäckhed</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites</article-title><source>Cell</source><year>2016</year><volume>165</volume><fpage>1332</fpage><lpage>1345</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28Xpslaltro%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.041</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macfarlane</surname><given-names>GT</given-names></name><name><surname>Macfarlane</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Bacteria, colonic fermentation, and gastrointestinal health</article-title><source>J AOAC Int</source><year>2012</year><volume>95</volume><fpage>50</fpage><lpage>60</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XjsFSisr8%3D</pub-id><pub-id pub-id-type="pmid">22468341</pub-id><pub-id pub-id-type="doi">10.5740/jaoacint.SGE_Macfarlane</pub-id><pub-id pub-id-type="pmcid">22468341</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mountfort</surname><given-names>DO</given-names></name><name><surname>Grant</surname><given-names>WD</given-names></name><name><surname>Clarke</surname><given-names>R</given-names></name><name><surname>Asher</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Eubacterium callanderi sp. nov. that demethoxylates O-methoxylated aromatic acids to volatile fatty acids</article-title><source>Int J Syst Evol Microbiol</source><year>1988</year><volume>38</volume><fpage>254</fpage><lpage>258</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL1cXlsVKisr0%3D</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>Julie A.K.</given-names></name><name><surname>Mullish</surname><given-names>Benjamin H.</given-names></name><name><surname>Pechlivanis</surname><given-names>Alexandros</given-names></name><name><surname>Liu</surname><given-names>Zhigang</given-names></name><name><surname>Brignardello</surname><given-names>Jerusa</given-names></name><name><surname>Kao</surname><given-names>Dina</given-names></name><name><surname>Holmes</surname><given-names>Elaine</given-names></name><name><surname>Li</surname><given-names>Jia V.</given-names></name><name><surname>Clarke</surname><given-names>Thomas B.</given-names></name><name><surname>Thursz</surname><given-names>Mark R.</given-names></name><name><surname>Marchesi</surname><given-names>Julian R.</given-names></name></person-group><article-title xml:lang="en">Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota</article-title><source>Gastroenterology</source><year>2018</year><volume>155</volume><issue>5</issue><fpage>1495-1507.e15</fpage><pub-id pub-id-type="pmid">30025704</pub-id><pub-id pub-id-type="pmcid">6347096</pub-id><pub-id pub-id-type="doi">10.1053/j.gastro.2018.07.014</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXitV2qtb%2FK</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>PG</given-names></name><name><surname>Biswas</surname><given-names>A</given-names></name><name><surname>Morales</surname><given-names>SE</given-names></name><name><surname>Greening</surname><given-names>C</given-names></name><name><surname>Gaskins</surname><given-names>HR</given-names></name></person-group><article-title xml:lang="en">H2 metabolism is widespread and diverse among human colonic microbes</article-title><source>Gut Microbes</source><year>2016</year><volume>7</volume><fpage>235</fpage><lpage>245</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XpslWqtbg%3D</pub-id><pub-id pub-id-type="pmid">27123663</pub-id><pub-id pub-id-type="pmcid">4939926</pub-id><pub-id pub-id-type="doi">10.1080/19490976.2016.1182288</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tailford</surname><given-names>LE</given-names></name><name><surname>Crost</surname><given-names>EH</given-names></name><name><surname>Kavanaugh</surname><given-names>D</given-names></name><name><surname>Juge</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Mucin glycan foraging in the human gut microbiome</article-title><source>Front Genet</source><year>2015</year><volume>6</volume><fpage>81</fpage><pub-id pub-id-type="pmid">25852737</pub-id><pub-id pub-id-type="pmcid">4365749</pub-id><pub-id pub-id-type="doi">10.3389/fgene.2015.00081</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXht1KjsbnK</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louis</surname><given-names>P</given-names></name><name><surname>Flint</surname><given-names>HJ</given-names></name></person-group><article-title xml:lang="en">Formation of propionate and butyrate by the human colonic microbiota</article-title><source>Environ Microbiol</source><year>2017</year><volume>19</volume><fpage>29</fpage><lpage>41</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhsFagu78%3D</pub-id><pub-id pub-id-type="pmid">27928878</pub-id><pub-id pub-id-type="doi">10.1111/1462-2920.13589</pub-id><pub-id pub-id-type="pmcid">27928878</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischbach</surname><given-names>MA</given-names></name><name><surname>Sonnenburg</surname><given-names>JL</given-names></name></person-group><article-title xml:lang="en">Eating for two: how metabolism establishes interspecies interactions in the gut</article-title><source>Cell Host Microbe</source><year>2011</year><volume>10</volume><fpage>336</fpage><lpage>347</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtlKitr7E</pub-id><pub-id pub-id-type="pmid">22018234</pub-id><pub-id pub-id-type="pmcid">3225337</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2011.10.002</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Vladar</surname><given-names>HP</given-names></name></person-group><article-title xml:lang="en">Amino acid fermentation at the origin of the genetic code</article-title><source>Biol Direct</source><year>2012</year><volume>7</volume><fpage>6</fpage><pub-id pub-id-type="pmid">22325238</pub-id><pub-id pub-id-type="pmcid">3376031</pub-id><pub-id pub-id-type="doi">10.1186/1745-6150-7-6</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XpsVWgs70%3D</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopetuso</surname><given-names>LR</given-names></name><name><surname>Scaldaferri</surname><given-names>F</given-names></name><name><surname>Petito</surname><given-names>V</given-names></name><name><surname>Gasbarrini</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Commensal clostridia: leading players in the maintenance of gut homeostasis</article-title><source>Gut Pathog</source><year>2013</year><volume>5</volume><fpage>23</fpage><pub-id pub-id-type="pmid">23941657</pub-id><pub-id pub-id-type="pmcid">3751348</pub-id><pub-id pub-id-type="doi">10.1186/1757-4749-5-23</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXptVyqsLo%3D</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokusaeva</surname><given-names>K</given-names></name><name><surname>Fitzgerald</surname><given-names>GF</given-names></name><name><surname>van Sinderen</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Carbohydrate metabolism in Bifidobacteria</article-title><source>Genes Nutr</source><year>2011</year><volume>6</volume><fpage>285</fpage><lpage>306</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXhtl2kur3O</pub-id><pub-id pub-id-type="pmid">21484167</pub-id><pub-id pub-id-type="pmcid">3145055</pub-id><pub-id pub-id-type="doi">10.1007/s12263-010-0206-6</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumas-Bilak</surname><given-names>E</given-names></name><name><surname>Carlier</surname><given-names>J-P</given-names></name><name><surname>Jean-Pierre</surname><given-names>H</given-names></name><name><surname>Teyssier</surname><given-names>C</given-names></name><name><surname>Gay</surname><given-names>B</given-names></name><name><surname>Campos</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en"><italic>Veillonella montpellierensis</italic> sp. nov., a novel, anaerobic, gram-negative coccus isolated from human clinical samples</article-title><source>Int J Syst Evol Microbiol</source><year>2004</year><volume>54</volume><fpage>1311</fpage><lpage>1316</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXnt1Gitrk%3D</pub-id><pub-id pub-id-type="pmid">15280307</pub-id><pub-id pub-id-type="doi">10.1099/ijs.0.02952-0</pub-id><pub-id pub-id-type="pmcid">15280307</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paixão</surname><given-names>L</given-names></name><name><surname>Oliveira</surname><given-names>J</given-names></name><name><surname>Veríssimo</surname><given-names>A</given-names></name><name><surname>Vinga</surname><given-names>S</given-names></name><name><surname>Lourenço</surname><given-names>EC</given-names></name><name><surname>Ventura</surname><given-names>MR</given-names></name><etal/></person-group><article-title xml:lang="en">Host glycan sugar-specific pathways in <italic>Streptococcus pneumonia</italic>: galactose as a key sugar in colonisation and infection</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0121042</fpage><pub-id pub-id-type="pmid">25826206</pub-id><pub-id pub-id-type="pmcid">4380338</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0121042</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhsFynu7bE</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>SH</given-names></name><name><surname>Hold</surname><given-names>GL</given-names></name><name><surname>Harmsen</surname><given-names>HJM</given-names></name><name><surname>Stewart</surname><given-names>CS</given-names></name><name><surname>Flint</surname><given-names>HJ</given-names></name></person-group><article-title xml:lang="en">Growth requirements and fermentation products of <italic>Fusobacterium prausnitzii</italic>, and a proposal to reclassify it as <italic>Faecalibacterium prausnitzii</italic> gen. Nov., comb. nov</article-title><source>Int J Syst Evol Microbiol</source><year>2002</year><volume>52</volume><fpage>2141</fpage><lpage>2146</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXht12htQ%3D%3D</pub-id><pub-id pub-id-type="pmid">12508881</pub-id><pub-id pub-id-type="pmcid">12508881</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charalampopoulos</surname><given-names>D</given-names></name><name><surname>Pandiella</surname><given-names>SS</given-names></name><name><surname>Webb</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Growth studies of potentially probiotic lactic acid bacteria in cereal-based substrates</article-title><source>J Appl Microbiol</source><year>2002</year><volume>92</volume><fpage>851</fpage><lpage>859</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XksVSrsLk%3D</pub-id><pub-id pub-id-type="pmid">11972688</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2672.2002.01592.x</pub-id><pub-id pub-id-type="pmcid">11972688</pub-id></mixed-citation></ref><ref id="CR48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taras</surname><given-names>D</given-names></name><name><surname>Simmering</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>MD</given-names></name><name><surname>Lawson</surname><given-names>PA</given-names></name><name><surname>Blaut</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Reclassification of <italic>Eubacterium formicigenerans</italic> Holdeman and Moore 1974 as <italic>Dorea formicigenerans</italic> gen. nov., comb. nov., and description of <italic>Dorea longicatena</italic> sp. nov., isolated from human faeces</article-title><source>Int J Syst Evol Microbiol</source><year>2002</year><volume>52</volume><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">11931151</pub-id><pub-id pub-id-type="doi">10.1099/00207713-52-2-423</pub-id><pub-id pub-id-type="pmcid">11931151</pub-id></mixed-citation></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holdeman</surname><given-names>LV</given-names></name><name><surname>Moore</surname><given-names>WEC</given-names></name></person-group><article-title xml:lang="en">New genus, <italic>Coprococcus</italic>, twelve new species, and emended descriptions of four previously described species of bacteria from human feces</article-title><source>Int J Syst Evol Microbiol</source><year>1974</year><volume>24</volume><fpage>260</fpage><lpage>277</lpage></mixed-citation></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Finegold</surname><given-names>SM</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><name><surname>Lawson</surname><given-names>PA</given-names></name></person-group><article-title xml:lang="en">Reclassification of <italic>Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus</italic> and <italic>Ruminococcus schinkii</italic> as <italic>Blautia coccoides</italic> gen. Nov., comb. nov., <italic>Blautia hansenii</italic> comb. nov., <italic>Blautia hydrogenotrophica</italic> comb. nov., <italic>Blautia luti</italic> comb. nov., <italic>Blautia producta</italic> comb. nov., <italic>Blautia schinkii</italic> comb. nov. and description of <italic>Blautia wexlerae</italic> sp. nov., isolated from human faeces</article-title><source>Int J Syst Evol Microbiol</source><year>2008</year><volume>58</volume><fpage>1896</fpage><lpage>1902</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtFens7vN</pub-id><pub-id pub-id-type="pmid">18676476</pub-id><pub-id pub-id-type="doi">10.1099/ijs.0.65208-0</pub-id><pub-id pub-id-type="pmcid">18676476</pub-id></mixed-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname><given-names>H</given-names></name><name><surname>Ko</surname><given-names>H-J</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Choi</surname><given-names>DG</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Complete genome sequence of a carbon monoxide-utilizing Acetogen, <italic>Eubacterium limosum</italic> KIST612</article-title><source>J Bacteriol</source><year>2011</year><volume>193</volume><fpage>307</fpage><lpage>308</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXisVyis7g%3D</pub-id><pub-id pub-id-type="pmid">21036996</pub-id><pub-id pub-id-type="doi">10.1128/JB.01217-10</pub-id><pub-id pub-id-type="pmcid">21036996</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polansky</surname><given-names>O</given-names></name><name><surname>Sekelova</surname><given-names>Z</given-names></name><name><surname>Faldynova</surname><given-names>M</given-names></name><name><surname>Sebkova</surname><given-names>A</given-names></name><name><surname>Sisak</surname><given-names>F</given-names></name><name><surname>Rychlik</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Important metabolic pathways and biological processes expressed by chicken cecal microbiota</article-title><source>Appl Environ Microbiol</source><year>2016</year><volume>82</volume><fpage>1569</fpage><lpage>1576</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsFOhsrjM</pub-id><pub-id pub-id-type="pmcid">4771310</pub-id><pub-id pub-id-type="doi">10.1128/AEM.03473-15</pub-id></mixed-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>M</given-names></name><name><surname>Benno</surname><given-names>Y</given-names></name></person-group><article-title xml:lang="en">Reclassification of <italic>Bacteroides distasonis</italic>, <italic>Bacteroides goldsteinii</italic> and <italic>Bacteroides merdae</italic> as <italic>Parabacteroides distasonis</italic> gen. nov., comb. nov., <italic>Parabacteroides goldsteinii</italic> comb. nov. and <italic>Parabacteroides merdae</italic> comb. nov</article-title><source>Int J Syst Evol Microbiol</source><year>2006</year><volume>56</volume><fpage>1599</fpage><lpage>1605</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD28XotlKlsbs%3D</pub-id><pub-id pub-id-type="pmid">16825636</pub-id><pub-id pub-id-type="doi">10.1099/ijs.0.64192-0</pub-id><pub-id pub-id-type="pmcid">16825636</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rautio</surname><given-names>M</given-names></name><name><surname>Eerola</surname><given-names>E</given-names></name><name><surname>Väisänen-Tunkelrott</surname><given-names>M-L</given-names></name><name><surname>Molitoris</surname><given-names>D</given-names></name><name><surname>Lawson</surname><given-names>P</given-names></name><name><surname>Collins</surname><given-names>MD</given-names></name><etal/></person-group><article-title xml:lang="en">Reclassification of <italic>Bacteroides putredinis</italic> (Weinberg et al., 1937) in a new genus <italic>Alistipes</italic> gen. nov., as <italic>Alistipes putredinis</italic> comb. nov., and description of <italic>Alistipes finegoldii</italic> sp. nov., from human sources</article-title><source>Syst Appl Microbiol</source><year>2003</year><volume>26</volume><fpage>182</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">12866844</pub-id><pub-id pub-id-type="doi">10.1078/072320203322346029</pub-id><pub-id pub-id-type="pmcid">12866844</pub-id></mixed-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneuchi</surname><given-names>C</given-names></name><name><surname>Miyazato</surname><given-names>T</given-names></name><name><surname>Shinjo</surname><given-names>T</given-names></name><name><surname>Mitsuoka</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Taxonomic study of helically coiled, Sporeforming anaerobes isolated from the intestines of humans and other animals: <italic>Clostridium cocleatum</italic> sp. nov. and <italic>Clostridium spiroforme</italic> sp. nov</article-title><source>Int J Syst Evol Microbiol</source><year>1979</year><volume>29</volume><fpage>1</fpage><lpage>12</lpage></mixed-citation></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yutin</surname><given-names>N</given-names></name><name><surname>Galperin</surname><given-names>MY</given-names></name></person-group><article-title xml:lang="en">A genomic update on clostridial phylogeny: gram-negative spore-formers and other misplaced clostridia</article-title><source>Environ Microbiol</source><year>2013</year><volume>15</volume><fpage>2631</fpage><lpage>2641</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhs1Slur3F</pub-id><pub-id pub-id-type="pmid">23834245</pub-id><pub-id pub-id-type="pmcid">4056668</pub-id></mixed-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>K</given-names></name><name><surname>Shen</surname><given-names>CR</given-names></name></person-group><article-title xml:lang="en">Selection of an endogenous 2,3-butanediol pathway in <italic>Escherichia coli</italic> by fermentative redox balance</article-title><source>Metab Eng</source><year>2017</year><volume>39</volume><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XitVSqsr7P</pub-id><pub-id pub-id-type="pmid">27931827</pub-id><pub-id pub-id-type="doi">10.1016/j.ymben.2016.11.012</pub-id><pub-id pub-id-type="pmcid">27931827</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chassard</surname><given-names>C</given-names></name><name><surname>Delmas</surname><given-names>E</given-names></name><name><surname>Robert</surname><given-names>C</given-names></name><name><surname>Lawson</surname><given-names>PA</given-names></name></person-group><article-title xml:lang="en">Bernalier-Donadille a. <italic>Ruminococcus champanellensis</italic> sp. nov., a cellulose-degrading bacterium from human gut microbiota</article-title><source>Int J Syst Evol Microbiol</source><year>2012</year><volume>62</volume><fpage>138</fpage><lpage>143</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XjsF2mu7w%3D</pub-id><pub-id pub-id-type="pmid">21357460</pub-id><pub-id pub-id-type="doi">10.1099/ijs.0.027375-0</pub-id><pub-id pub-id-type="pmcid">21357460</pub-id></mixed-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashima</surname><given-names>I</given-names></name><name><surname>Liao</surname><given-names>Y-C</given-names></name><name><surname>Miyakawa</surname><given-names>H</given-names></name><name><surname>Theodorea</surname><given-names>CF</given-names></name><name><surname>Thawboon</surname><given-names>B</given-names></name><name><surname>Thaweboon</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en"><italic>Veillonella infantium</italic> sp. nov., an anaerobic, gram-stain-negative coccus isolated from tongue biofilm of a Thai child</article-title><source>Int J Syst Evol Microbiol</source><year>2018</year><volume>68</volume><fpage>1101</fpage><lpage>1106</lpage><pub-id pub-id-type="pmid">29458564</pub-id><pub-id pub-id-type="doi">10.1099/ijsem.0.002632</pub-id><pub-id pub-id-type="pmcid">29458564</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elshaghabee</surname><given-names>FMF</given-names></name><name><surname>Bockelmann</surname><given-names>W</given-names></name><name><surname>Meske</surname><given-names>D</given-names></name><name><surname>de Vrese</surname><given-names>M</given-names></name><name><surname>Walte</surname><given-names>H-G</given-names></name><name><surname>Schrezenmeir</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Ethanol production by selected intestinal microorganisms and lactic acid bacteria growing under different nutritional conditions</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>47</fpage><pub-id pub-id-type="pmid">26858714</pub-id><pub-id pub-id-type="pmcid">4732544</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.00047</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>WJ</given-names></name><name><surname>Henderson</surname><given-names>G</given-names></name><name><surname>Pacheco</surname><given-names>DM</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Reilly</surname><given-names>K</given-names></name><name><surname>Naylor</surname><given-names>GE</given-names></name><etal/></person-group><article-title xml:lang="en">The complete genome sequence of <italic>Eubacterium limosum</italic> SA11, a metabolically versatile rumen acetogen</article-title><source>Stand Genomic Sci</source><year>2016</year><volume>11</volume><fpage>26</fpage><pub-id pub-id-type="pmid">26981167</pub-id><pub-id pub-id-type="pmcid">4791908</pub-id><pub-id pub-id-type="doi">10.1186/s40793-016-0147-9</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXms1Gru7w%3D</pub-id></mixed-citation></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrison</surname><given-names>DJ</given-names></name><name><surname>Preston</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism</article-title><source>Gut Microbes</source><year>2016</year><volume>7</volume><fpage>189</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">4939913</pub-id><pub-id pub-id-type="pmcid">4939913</pub-id><pub-id pub-id-type="doi">10.1080/19490976.2015.1134082</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>den Besten</surname><given-names>G</given-names></name><name><surname>van Eunen</surname><given-names>K</given-names></name><name><surname>Groen</surname><given-names>AK</given-names></name><name><surname>Venema</surname><given-names>K</given-names></name><name><surname>Reijngoud</surname><given-names>D-J</given-names></name><name><surname>Bakker</surname><given-names>BM</given-names></name></person-group><article-title xml:lang="en">The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism</article-title><source>J Lipid Res</source><year>2013</year><volume>54</volume><fpage>2325</fpage><lpage>2340</lpage><pub-id pub-id-type="doi">10.1194/jlr.R036012</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXht1aqsbrO</pub-id></mixed-citation></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ríos-Covián</surname><given-names>D</given-names></name><name><surname>Ruas-Madiedo</surname><given-names>P</given-names></name><name><surname>Margolles</surname><given-names>A</given-names></name><name><surname>Gueimonde</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">de los Reyes-Gavilán CG, Salazar N. intestinal short chain fatty acids and their link with diet and human health</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>185</fpage><pub-id pub-id-type="pmid">26925050</pub-id><pub-id pub-id-type="pmcid">4756104</pub-id><pub-id pub-id-type="doi">10.3389/fmicb.2016.00185</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>W-J</given-names></name><name><surname>Hase</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Gut microbiota-generated metabolites in animal health and disease</article-title><source>Nat Chem Biol</source><year>2014</year><volume>10</volume><fpage>416</fpage><lpage>424</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXotFeqtr8%3D</pub-id><pub-id pub-id-type="pmid">24838170</pub-id><pub-id pub-id-type="doi">10.1038/nchembio.1535</pub-id><pub-id pub-id-type="pmcid">24838170</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishina</surname><given-names>PM</given-names></name><name><surname>Freedland</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Effects of propionate on lipid biosynthesis in isolated rat hepatocytes</article-title><source>J Nutr</source><year>1990</year><volume>120</volume><fpage>668</fpage><lpage>673</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK3cXkvFGhs70%3D</pub-id><pub-id pub-id-type="pmid">2366102</pub-id><pub-id pub-id-type="doi">10.1093/jn/120.7.668</pub-id><pub-id pub-id-type="pmcid">2366102</pub-id></mixed-citation></ref><ref id="CR67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname><given-names>ES</given-names></name><name><surname>Viardot</surname><given-names>A</given-names></name><name><surname>Psichas</surname><given-names>A</given-names></name><name><surname>Morrison</surname><given-names>DJ</given-names></name><name><surname>Murphy</surname><given-names>KG</given-names></name><name><surname>Zac-Varghese</surname><given-names>SEK</given-names></name><etal/></person-group><article-title xml:lang="en">Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults</article-title><source>Gut</source><year>2015</year><volume>64</volume><fpage>1744</fpage><lpage>1754</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhtVKrsbbE</pub-id><pub-id pub-id-type="pmid">25500202</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2014-307913</pub-id><pub-id pub-id-type="pmcid">25500202</pub-id></mixed-citation></ref><ref id="CR68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Layden</surname><given-names>BT</given-names></name><name><surname>Yalamanchi</surname><given-names>SK</given-names></name><name><surname>Wolever</surname><given-names>TM</given-names></name><name><surname>Dunaif</surname><given-names>A</given-names></name><name><surname>Lowe</surname><given-names>WL</given-names></name></person-group><article-title xml:lang="en">Negative association of acetate with visceral adipose tissue and insulin levels</article-title><source>Diabetes Metab Syndr Obes Targets Ther</source><year>2012</year><volume>5</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XktlSlt7o%3D</pub-id><pub-id pub-id-type="doi">10.2147/DMSO.S29244</pub-id></mixed-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorokhov</surname><given-names>YL</given-names></name><name><surname>Shindyapina</surname><given-names>AV</given-names></name><name><surname>Sheshukova</surname><given-names>EV</given-names></name><name><surname>Komarova</surname><given-names>TV</given-names></name></person-group><article-title xml:lang="en">Metabolic methanol: molecular pathways and physiological roles</article-title><source>Physiol Rev</source><year>2015</year><volume>95</volume><fpage>603</fpage><lpage>644</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXmtlWit7s%3D</pub-id><pub-id pub-id-type="pmid">25834233</pub-id><pub-id pub-id-type="doi">10.1152/physrev.00034.2014</pub-id><pub-id pub-id-type="pmcid">25834233</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gkolfakis</surname><given-names>P</given-names></name><name><surname>Dimitriadis</surname><given-names>G</given-names></name><name><surname>Triantafyllou</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Gut microbiota and non-alcoholic fatty liver disease</article-title><source>Hepatobiliary Pancreat Dis Int</source><year>2015</year><volume>14</volume><fpage>572</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">26663004</pub-id><pub-id pub-id-type="doi">10.1016/S1499-3872(15)60026-1</pub-id><pub-id pub-id-type="pmcid">26663004</pub-id></mixed-citation></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>PJ</given-names></name><name><surname>Siraki</surname><given-names>AG</given-names></name><name><surname>Shangari</surname><given-names>N</given-names></name></person-group><article-title xml:lang="en">Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health</article-title><source>Crit Rev Toxicol</source><year>2005</year><volume>35</volume><fpage>609</fpage><lpage>662</lpage><pub-id pub-id-type="pmid">16417045</pub-id><pub-id pub-id-type="doi">10.1080/10408440591002183</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXht1agtr3L</pub-id><pub-id pub-id-type="pmcid">16417045</pub-id></mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Baker</surname><given-names>SS</given-names></name><name><surname>Gill</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Alkhouri</surname><given-names>R</given-names></name><name><surname>Baker</surname><given-names>RD</given-names></name><etal/></person-group><article-title xml:lang="en">Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH</article-title><source>Hepatology</source><year>2013</year><volume>57</volume><fpage>601</fpage><lpage>609</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXit1Wgsbo%3D</pub-id><pub-id pub-id-type="pmid">23055155</pub-id><pub-id pub-id-type="doi">10.1002/hep.26093</pub-id><pub-id pub-id-type="pmcid">23055155</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>ER</given-names></name><name><surname>Zisman</surname><given-names>TL</given-names></name><name><surname>Suskind</surname><given-names>DL</given-names></name></person-group><article-title xml:lang="en">The microbiota in inflammatory bowel disease: current and therapeutic insights</article-title><source>J Inflamm Res</source><year>2017</year><volume>10</volume><fpage>63</fpage><lpage>73</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXit1SrsLnL</pub-id><pub-id pub-id-type="pmid">28652796</pub-id><pub-id pub-id-type="pmcid">5473501</pub-id><pub-id pub-id-type="doi">10.2147/JIR.S116088</pub-id></mixed-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Principi</surname><given-names>M</given-names></name><name><surname>Iannone</surname><given-names>A</given-names></name><name><surname>Losurdo</surname><given-names>G</given-names></name><name><surname>Mangia</surname><given-names>M</given-names></name><name><surname>Shahini</surname><given-names>E</given-names></name><name><surname>Albano</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Nonalcoholic fatty liver disease in inflammatory bowel disease: prevalence and risk factors</article-title><source>Inflamm Bowel Dis</source><year>2018</year><volume>24</volume><fpage>1589</fpage><lpage>1596</lpage><pub-id pub-id-type="pmid">29688336</pub-id><pub-id pub-id-type="doi">10.1093/ibd/izy051</pub-id><pub-id pub-id-type="pmcid">29688336</pub-id></mixed-citation></ref><ref id="CR75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">KEGG: Kyoto encyclopedia of genes and genomes</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><fpage>27</fpage><lpage>30</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3cXhvVGqu74%3D</pub-id><pub-id pub-id-type="pmid">10592173</pub-id><pub-id pub-id-type="pmcid">10592173</pub-id><pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id></mixed-citation></ref><ref id="CR76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinnebusch</surname><given-names>BF</given-names></name><name><surname>Meng</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>JT</given-names></name><name><surname>Archer</surname><given-names>SY</given-names></name><name><surname>Hodin</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation</article-title><source>J Nutr</source><year>2002</year><volume>132</volume><fpage>1012</fpage><lpage>1017</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XjvFSnsbg%3D</pub-id><pub-id pub-id-type="pmid">11983830</pub-id><pub-id pub-id-type="doi">10.1093/jn/132.5.1012</pub-id><pub-id pub-id-type="pmcid">11983830</pub-id></mixed-citation></ref><ref id="CR77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miceli</surname><given-names>JF</given-names></name><name><surname>Torres</surname><given-names>CI</given-names></name><name><surname>Krajmalnik-Brown</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Shifting the balance of fermentation products between hydrogen and volatile fatty acids: microbial community structure and function</article-title><source>FEMS Microbiol Ecol</source><year>2016</year><volume>92</volume><fpage>fiw195</fpage><pub-id pub-id-type="pmid">27633926</pub-id><pub-id pub-id-type="pmcid">5975917</pub-id><pub-id pub-id-type="doi">10.1093/femsec/fiw195</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhsVehsL%2FO</pub-id></mixed-citation></ref><ref id="CR78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mack</surname><given-names>I</given-names></name><name><surname>Cuntz</surname><given-names>U</given-names></name><name><surname>Grämer</surname><given-names>C</given-names></name><name><surname>Niedermaier</surname><given-names>S</given-names></name><name><surname>Pohl</surname><given-names>C</given-names></name><name><surname>Schwiertz</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>26752</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XptVSktL4%3D</pub-id><pub-id pub-id-type="pmid">27229737</pub-id><pub-id pub-id-type="pmcid">4882621</pub-id><pub-id pub-id-type="doi">10.1038/srep26752</pub-id></mixed-citation></ref><ref id="CR79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armougom</surname><given-names>F</given-names></name><name><surname>Henry</surname><given-names>M</given-names></name><name><surname>Vialettes</surname><given-names>B</given-names></name><name><surname>Raccah</surname><given-names>D</given-names></name><name><surname>Raoult</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Monitoring bacterial Community of Human gut Microbiota Reveals an increase in lactobacillus in obese patients and methanogens in anorexic patients</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e7125</fpage><pub-id pub-id-type="pmid">19774074</pub-id><pub-id pub-id-type="pmcid">2742902</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0007125</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtF2gt7zL</pub-id></mixed-citation></ref><ref id="CR80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rey</surname><given-names>FE</given-names></name><name><surname>Gonzalez</surname><given-names>MD</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Ahern</surname><given-names>PP</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title xml:lang="en">Metabolic niche of a prominent sulfate-reducing human gut bacterium</article-title><source>Proc Natl Acad Sci U S A</source><year>2013</year><volume>110</volume><fpage>13582</fpage><lpage>13587</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtlCrtbjN</pub-id><pub-id pub-id-type="pmid">23898195</pub-id><pub-id pub-id-type="pmcid">3746858</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1312524110</pub-id></mixed-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjdia</surname><given-names>A</given-names></name><name><surname>Martens</surname><given-names>EC</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name><name><surname>Berteau</surname><given-names>O</given-names></name></person-group><article-title xml:lang="en">Sulfatases and a radical S-adenosyl-L-methionine (AdoMet) enzyme are key for mucosal foraging and fitness of the prominent human gut symbiont, <italic>Bacteroides thetaiotaomicron</italic></article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>25973</fpage><lpage>25982</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXovFCku74%3D</pub-id><pub-id pub-id-type="pmid">21507958</pub-id><pub-id pub-id-type="pmcid">3138274</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M111.228841</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name></person-group><article-title xml:lang="en">Sulphide as an inhibitor and electron donor for the cytochrome c oxidase system</article-title><source>Can J Biochem</source><year>1982</year><volume>60</volume><fpage>613</fpage><lpage>623</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL38XkvVOksLs%3D</pub-id><pub-id pub-id-type="pmid">6288202</pub-id><pub-id pub-id-type="doi">10.1139/o82-076</pub-id><pub-id pub-id-type="pmcid">6288202</pub-id></mixed-citation></ref><ref id="CR83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Figliuolo</surname><given-names>VR</given-names></name><name><surname>dos Santos</surname><given-names>LM</given-names></name><name><surname>Abalo</surname><given-names>A</given-names></name><name><surname>Nanini</surname><given-names>H</given-names></name><name><surname>Santos</surname><given-names>A</given-names></name><name><surname>Brittes</surname><given-names>NM</given-names></name><etal/></person-group><article-title xml:lang="en">Sulfate-reducing bacteria stimulate gut immune responses and contribute to inflammation in experimental colitis</article-title><source>Life Sci</source><year>2017</year><volume>189</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhsFent7fL</pub-id><pub-id pub-id-type="pmid">28912045</pub-id><pub-id pub-id-type="doi">10.1016/j.lfs.2017.09.014</pub-id><pub-id pub-id-type="pmcid">28912045</pub-id></mixed-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ijssennagger</surname><given-names>N</given-names></name><name><surname>Belzer</surname><given-names>C</given-names></name><name><surname>Hooiveld</surname><given-names>GJ</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>van Mil</surname><given-names>SWC</given-names></name><name><surname>Müller</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon</article-title><source>Proc Natl Acad Sci U S A</source><year>2015</year><volume>112</volume><fpage>10038</fpage><lpage>10043</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXht1Crt7rP</pub-id><pub-id pub-id-type="pmid">26216954</pub-id><pub-id pub-id-type="pmcid">4538683</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1507645112</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ijssennagger</surname><given-names>N</given-names></name><name><surname>van der</surname><given-names>MR</given-names></name><name><surname>van</surname><given-names>MSWC</given-names></name></person-group><article-title xml:lang="en">Sulfide as a mucus barrier-breaker in inflammatory bowel disease?</article-title><source>Trends Mol Med</source><year>2016</year><volume>22</volume><fpage>190</fpage><lpage>199</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhsFKhtbs%3D</pub-id><pub-id pub-id-type="pmid">26852376</pub-id><pub-id pub-id-type="doi">10.1016/j.molmed.2016.01.002</pub-id><pub-id pub-id-type="pmcid">26852376</pub-id></mixed-citation></ref><ref id="CR86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>L</given-names></name><name><surname>Myrmel</surname><given-names>LS</given-names></name><name><surname>Fjære</surname><given-names>E</given-names></name><name><surname>Liaset</surname><given-names>B</given-names></name><name><surname>Kristiansen</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">Links between dietary protein sources, the gut microbiota, and obesity</article-title><source>Front Physiol</source><year>2017</year><volume>8</volume><fpage>1047</fpage><pub-id pub-id-type="pmid">29311977</pub-id><pub-id pub-id-type="pmcid">5742165</pub-id><pub-id pub-id-type="doi">10.3389/fphys.2017.01047</pub-id></mixed-citation></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andriamihaja</surname><given-names>M</given-names></name><name><surname>Davila</surname><given-names>A-M</given-names></name><name><surname>Eklou-Lawson</surname><given-names>M</given-names></name><name><surname>Petit</surname><given-names>N</given-names></name><name><surname>Delpal</surname><given-names>S</given-names></name><name><surname>Allek</surname><given-names>F</given-names></name><etal/></person-group><article-title xml:lang="en">Colon luminal content and epithelial cell morphology are markedly modified in rats fed with a high-protein diet</article-title><source>Am J Physiol-Gastrointest Liver Physiol</source><year>2010</year><volume>299</volume><fpage>G1030</fpage><lpage>G1037</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsFSnsr7M</pub-id><pub-id pub-id-type="pmid">20689060</pub-id><pub-id pub-id-type="doi">10.1152/ajpgi.00149.2010</pub-id><pub-id pub-id-type="pmcid">20689060</pub-id></mixed-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>Roisin</given-names></name><name><surname>Kurth</surname><given-names>Mary Jo</given-names></name><name><surname>McGilligan</surname><given-names>Victoria</given-names></name><name><surname>McGlynn</surname><given-names>Hugh</given-names></name><name><surname>Rowland</surname><given-names>Ian</given-names></name></person-group><article-title xml:lang="en">Effect of Colonic Bacterial Metabolites on Caco-2 Cell Paracellular Permeability In Vitro</article-title><source>Nutrition and Cancer</source><year>2008</year><volume>60</volume><issue>2</issue><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXovFKrtrY%3D</pub-id><pub-id pub-id-type="pmid">18444159</pub-id><pub-id pub-id-type="doi">10.1080/01635580701649644</pub-id><pub-id pub-id-type="pmcid">18444159</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cremin</surname><given-names>JD</given-names></name><name><surname>Fitch</surname><given-names>MD</given-names></name><name><surname>Fleming</surname><given-names>SE</given-names></name></person-group><article-title xml:lang="en">Glucose alleviates ammonia-induced inhibition of short-chain fatty acid metabolism in rat colonic epithelial cells</article-title><source>Am J Physiol-Gastrointest Liver Physiol</source><year>2003</year><volume>285</volume><fpage>G105</fpage><lpage>G114</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXls1Wms7s%3D</pub-id><pub-id pub-id-type="pmid">12637251</pub-id><pub-id pub-id-type="doi">10.1152/ajpgi.00437.2002</pub-id><pub-id pub-id-type="pmcid">12637251</pub-id></mixed-citation></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eklou-Lawson</surname><given-names>M</given-names></name><name><surname>Bernard</surname><given-names>F</given-names></name><name><surname>Neveux</surname><given-names>N</given-names></name><name><surname>Chaumontet</surname><given-names>C</given-names></name><name><surname>Bos</surname><given-names>C</given-names></name><name><surname>Davila-Gay</surname><given-names>A-M</given-names></name><etal/></person-group><article-title xml:lang="en">Colonic luminal ammonia and portal blood l-glutamine and l-arginine concentrations: a possible link between colon mucosa and liver ureagenesis</article-title><source>Amino Acids</source><year>2009</year><volume>37</volume><fpage>751</fpage><lpage>760</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtFyqt7jF</pub-id><pub-id pub-id-type="pmid">19082688</pub-id><pub-id pub-id-type="doi">10.1007/s00726-008-0218-3</pub-id><pub-id pub-id-type="pmcid">19082688</pub-id></mixed-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouillé</surname><given-names>B</given-names></name><name><surname>Robert</surname><given-names>V</given-names></name><name><surname>Blachier</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Adaptative increase of ornithine production and decrease of ammonia metabolism in rat colonocytes after hyperproteic diet ingestion</article-title><source>Am J Physiol-Gastrointest Liver Physiol</source><year>2004</year><volume>287</volume><fpage>G344</fpage><lpage>G351</lpage><pub-id pub-id-type="pmid">15064231</pub-id><pub-id pub-id-type="doi">10.1152/ajpgi.00445.2003</pub-id><pub-id pub-id-type="pmcid">15064231</pub-id></mixed-citation></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>EA</given-names></name><name><surname>Macfarlane</surname><given-names>GT</given-names></name></person-group><article-title xml:lang="en">Dissimilatory amino acid metabolism in human colonic bacteria</article-title><source>Anaerobe</source><year>1997</year><volume>3</volume><fpage>327</fpage><lpage>337</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXkvFOquw%3D%3D</pub-id><pub-id pub-id-type="pmid">16887608</pub-id><pub-id pub-id-type="doi">10.1006/anae.1997.0121</pub-id><pub-id pub-id-type="pmcid">16887608</pub-id></mixed-citation></ref><ref id="CR93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heimann</surname><given-names>E</given-names></name><name><surname>Nyman</surname><given-names>M</given-names></name><name><surname>Pålbrink</surname><given-names>A-K</given-names></name><name><surname>Lindkvist-Petersson</surname><given-names>K</given-names></name><name><surname>Degerman</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Branched short-chain fatty acids modulate glucose and lipid metabolism in primary adipocytes</article-title><source>Adipocyte</source><year>2016</year><volume>5</volume><fpage>359</fpage><lpage>368</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XitVGnurfF</pub-id><pub-id pub-id-type="pmid">27994949</pub-id><pub-id pub-id-type="pmcid">5160390</pub-id><pub-id pub-id-type="doi">10.1080/21623945.2016.1252011</pub-id></mixed-citation></ref><ref id="CR94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaskiewicz</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Hawes</surname><given-names>JW</given-names></name><name><surname>Shimomura</surname><given-names>Y</given-names></name><name><surname>Crabb</surname><given-names>DW</given-names></name><name><surname>Harris</surname><given-names>RA</given-names></name></person-group><article-title xml:lang="en">Catabolism of isobutyrate by colonocytes</article-title><source>Arch Biochem Biophys</source><year>1996</year><volume>327</volume><fpage>265</fpage><lpage>270</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK28Xhs1ajsb4%3D</pub-id><pub-id pub-id-type="pmid">8619613</pub-id><pub-id pub-id-type="doi">10.1006/abbi.1996.0120</pub-id><pub-id pub-id-type="pmcid">8619613</pub-id></mixed-citation></ref><ref id="CR95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tangerman</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">Measurement and biological significance of the volatile sulfur compounds hydrogen sulfide, methanethiol and dimethyl sulfide in various biological matrices</article-title><source>J Chromatogr B</source><year>2009</year><volume>877</volume><fpage>3366</fpage><lpage>3377</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtFGqtLbF</pub-id><pub-id pub-id-type="doi">10.1016/j.jchromb.2009.05.026</pub-id></mixed-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furne</surname><given-names>J</given-names></name><name><surname>Springfield</surname><given-names>J</given-names></name><name><surname>Koenig</surname><given-names>T</given-names></name><name><surname>DeMaster</surname><given-names>E</given-names></name><name><surname>Levitt</surname><given-names>MD</given-names></name></person-group><article-title xml:lang="en">Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa</article-title><source>Biochem Pharmacol</source><year>2001</year><volume>62</volume><fpage>255</fpage><lpage>259</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3MXktVOitLc%3D</pub-id><pub-id pub-id-type="pmid">11389886</pub-id><pub-id pub-id-type="doi">10.1016/S0006-2952(01)00657-8</pub-id><pub-id pub-id-type="pmcid">11389886</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugin</surname><given-names>B</given-names></name><name><surname>Barcik</surname><given-names>W</given-names></name><name><surname>Westermann</surname><given-names>P</given-names></name><name><surname>Heider</surname><given-names>A</given-names></name><name><surname>Wawrzyniak</surname><given-names>M</given-names></name><name><surname>Hellings</surname><given-names>P</given-names></name><etal/></person-group><article-title xml:lang="en">A wide diversity of bacteria from the human gut produces and degrades biogenic amines</article-title><source>Microb Ecol Health Dis</source><year>2017</year><volume>28</volume><fpage>1353881</fpage><pub-id pub-id-type="pmid">28959180</pub-id><pub-id pub-id-type="pmcid">5614385</pub-id><pub-id pub-id-type="doi">10.1080/16512235.2017.1353881</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXntl2htrs%3D</pub-id></mixed-citation></ref><ref id="CR98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayeur</surname><given-names>C</given-names></name><name><surname>Veuillet</surname><given-names>G</given-names></name><name><surname>Michaud</surname><given-names>M</given-names></name><name><surname>Raul</surname><given-names>F</given-names></name><name><surname>Blottière</surname><given-names>HM</given-names></name><name><surname>Blachier</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Effects of agmatine accumulation in human colon carcinoma cells on polyamine metabolism, DNA synthesis and the cell cycle</article-title><source>Biochim Biophys Acta BBA - Mol Cell Res</source><year>2005</year><volume>1745</volume><fpage>111</fpage><lpage>123</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2MXns1Wjt70%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.bbamcr.2004.12.004</pub-id></mixed-citation></ref><ref id="CR99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissim</surname><given-names>I</given-names></name><name><surname>Horyn</surname><given-names>O</given-names></name><name><surname>Daikhin</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Wehrli</surname><given-names>SL</given-names></name><etal/></person-group><article-title xml:lang="en">The molecular and metabolic influence of long term agmatine consumption</article-title><source>J Biol Chem</source><year>2014</year><volume>289</volume><fpage>9710</fpage><lpage>9729</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXls1Wqt74%3D</pub-id><pub-id pub-id-type="pmid">24523404</pub-id><pub-id pub-id-type="pmcid">3975019</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M113.544726</pub-id></mixed-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auguet</surname><given-names>M</given-names></name><name><surname>Viossat</surname><given-names>I</given-names></name><name><surname>Marin</surname><given-names>JG</given-names></name><name><surname>Chabrier</surname><given-names>PE</given-names></name></person-group><article-title xml:lang="en">Selective inhibition of inducible nitric oxide synthase by agmatine</article-title><source>Jpn J Pharmacol</source><year>1995</year><volume>69</volume><fpage>285</fpage><lpage>287</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2MXpsFCju7o%3D</pub-id><pub-id pub-id-type="pmid">8699639</pub-id><pub-id pub-id-type="doi">10.1254/jjp.69.285</pub-id><pub-id pub-id-type="pmcid">8699639</pub-id></mixed-citation></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reis</surname><given-names>DJ</given-names></name><name><surname>Regunathan</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Is agmatine a novel neurotransmitter in brain?</article-title><source>Trends Pharmacol Sci</source><year>2000</year><volume>21</volume><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3cXjtVeqs7k%3D</pub-id><pub-id pub-id-type="pmid">10785653</pub-id><pub-id pub-id-type="doi">10.1016/S0165-6147(00)01460-7</pub-id><pub-id pub-id-type="pmcid">10785653</pub-id></mixed-citation></ref><ref id="CR102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mouillé</surname><given-names>B</given-names></name><name><surname>Delpal</surname><given-names>S</given-names></name><name><surname>Mayeur</surname><given-names>C</given-names></name><name><surname>Blachier</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Inhibition of human colon carcinoma cell growth by ammonia: a non-cytotoxic process associated with polyamine synthesis reduction</article-title><source>Biochim Biophys Acta BBA - Gen Subj</source><year>2003</year><volume>1624</volume><fpage>88</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.bbagen.2003.09.014</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXpt1ersrc%3D</pub-id></mixed-citation></ref><ref id="CR103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>T</given-names></name><name><surname>Knauer</surname><given-names>H</given-names></name><name><surname>Schauer</surname><given-names>A</given-names></name><name><surname>Büttner</surname><given-names>S</given-names></name><name><surname>Ruckenstuhl</surname><given-names>C</given-names></name><name><surname>Carmona-Gutierrez</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">Induction of autophagy by spermidine promotes longevity</article-title><source>Nat Cell Biol</source><year>2009</year><volume>11</volume><fpage>1305</fpage><lpage>1314</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtlCnu73E</pub-id><pub-id pub-id-type="pmid">19801973</pub-id><pub-id pub-id-type="doi">10.1038/ncb1975</pub-id><pub-id pub-id-type="pmcid">19801973</pub-id></mixed-citation></ref><ref id="CR104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Rao</surname><given-names>JN</given-names></name><name><surname>Zou</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Marasa</surname><given-names>BS</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Polyamines are required for expression of toll-like receptor 2 modulating intestinal epithelial barrier integrity</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2007</year><volume>293</volume><fpage>G568</fpage><lpage>G576</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtVOqsbvN</pub-id><pub-id pub-id-type="pmid">17600044</pub-id><pub-id pub-id-type="doi">10.1152/ajpgi.00201.2007</pub-id><pub-id pub-id-type="pmcid">17600044</pub-id></mixed-citation></ref><ref id="CR105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>JN</given-names></name><name><surname>Rathor</surname><given-names>N</given-names></name><name><surname>Zhuang</surname><given-names>R</given-names></name><name><surname>Zou</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Polyamines regulate intestinal epithelial restitution through TRPC1-mediated Ca<sup>2</sup>+ signaling by differentially modulating STIM1 and STIM2</article-title><source>Am J Physiol Cell Physiol</source><year>2012</year><volume>303</volume><fpage>C308</fpage><lpage>C317</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtlSlu7zJ</pub-id><pub-id pub-id-type="pmid">22592407</pub-id><pub-id pub-id-type="pmcid">3423028</pub-id><pub-id pub-id-type="doi">10.1152/ajpcell.00120.2012</pub-id></mixed-citation></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buts</surname><given-names>Jean-Paul</given-names></name><name><surname>De Keyser</surname><given-names>Nadine</given-names></name><name><surname>Kolanowski</surname><given-names>Jaroslaw</given-names></name><name><surname>Sokal</surname><given-names>Etienne</given-names></name><name><surname>Van Hoof</surname><given-names>Francois</given-names></name></person-group><article-title xml:lang="en">Maturation of villus and crypt cell functions in rat small intestine</article-title><source>Digestive Diseases and Sciences</source><year>1993</year><volume>38</volume><issue>6</issue><fpage>1091</fpage><lpage>1098</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK3sXltFKitb8%3D</pub-id><pub-id pub-id-type="pmid">8508705</pub-id><pub-id pub-id-type="doi">10.1007/BF01295726</pub-id><pub-id pub-id-type="pmcid">8508705</pub-id></mixed-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kibe</surname><given-names>R</given-names></name><name><surname>Kurihara</surname><given-names>S</given-names></name><name><surname>Sakai</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>H</given-names></name><name><surname>Ooga</surname><given-names>T</given-names></name><name><surname>Sawaki</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice</article-title><source>Sci Rep</source><year>2014</year><volume>4</volume><fpage>4548</fpage><pub-id pub-id-type="pmid">24686447</pub-id><pub-id pub-id-type="pmcid">4070089</pub-id><pub-id pub-id-type="doi">10.1038/srep04548</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXptVyjurk%3D</pub-id></mixed-citation></ref><ref id="CR108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haskó</surname><given-names>G</given-names></name><name><surname>Kuhel</surname><given-names>DG</given-names></name><name><surname>Marton</surname><given-names>A</given-names></name><name><surname>Nemeth</surname><given-names>ZH</given-names></name><name><surname>Deitch</surname><given-names>EA</given-names></name><name><surname>Szabó</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">Spermine differentially regulates the production of interleukin-12 p40 and interleukin-10 and suppresses the release of the T helper 1 cytokine interferon-gamma</article-title><source>Shock Augusta Ga</source><year>2000</year><volume>14</volume><fpage>144</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1097/00024382-200014020-00012</pub-id></mixed-citation></ref><ref id="CR109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>JA</given-names></name><name><surname>Forsythe</surname><given-names>P</given-names></name><name><surname>Chew</surname><given-names>MV</given-names></name><name><surname>Escaravage</surname><given-names>E</given-names></name><name><surname>Savignac</surname><given-names>HM</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name><etal/></person-group><article-title xml:lang="en">Ingestion of <italic>Lactobacillus</italic> strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve</article-title><source>Proc Natl Acad Sci</source><year>2011</year><volume>108</volume><fpage>16050</fpage><lpage>16055</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXht1ekt7nF</pub-id><pub-id pub-id-type="pmid">21876150</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1102999108</pub-id><pub-id pub-id-type="pmcid">21876150</pub-id></mixed-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>CY</given-names></name></person-group><article-title xml:lang="en">Lin H-TV, Tsai GJ. Gamma-aminobutyric acid production in black soybean milk by <italic>Lactobacillus brevis</italic> FPA 3709 and the antidepressant effect of the fermented product on a forced swimming rat model</article-title><source>Process Biochem</source><year>2013</year><volume>48</volume><fpage>559</fpage><lpage>568</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXjvFCms7o%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.procbio.2013.02.021</pub-id></mixed-citation></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pokusaeva</surname><given-names>K.</given-names></name><name><surname>Johnson</surname><given-names>C.</given-names></name><name><surname>Luk</surname><given-names>B.</given-names></name><name><surname>Uribe</surname><given-names>G.</given-names></name><name><surname>Fu</surname><given-names>Y.</given-names></name><name><surname>Oezguen</surname><given-names>N.</given-names></name><name><surname>Matsunami</surname><given-names>R. K.</given-names></name><name><surname>Lugo</surname><given-names>M.</given-names></name><name><surname>Major</surname><given-names>A.</given-names></name><name><surname>Mori-Akiyama</surname><given-names>Y.</given-names></name><name><surname>Hollister</surname><given-names>E. B.</given-names></name><name><surname>Dann</surname><given-names>S. M.</given-names></name><name><surname>Shi</surname><given-names>X. Z.</given-names></name><name><surname>Engler</surname><given-names>D. A.</given-names></name><name><surname>Savidge</surname><given-names>T.</given-names></name><name><surname>Versalovic</surname><given-names>J.</given-names></name></person-group><article-title xml:lang="en">GABA-producing Bifidobacterium dentium modulates visceral sensitivity in the intestine</article-title><source>Neurogastroenterology &amp; Motility</source><year>2016</year><volume>29</volume><issue>1</issue><fpage>e12904</fpage><pub-id pub-id-type="doi">10.1111/nmo.12904</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXit1GmtQ%3D%3D</pub-id></mixed-citation></ref><ref id="CR112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjurstöm</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ericsson</surname><given-names>I</given-names></name><name><surname>Bengtsson</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">GABA, a natural immunomodulator of T lymphocytes</article-title><source>J Neuroimmunol</source><year>2008</year><volume>205</volume><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">18954912</pub-id><pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.08.017</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhsVWrsb%2FI</pub-id><pub-id pub-id-type="pmcid">18954912</pub-id></mixed-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bercik</surname><given-names>P</given-names></name><name><surname>Verdu</surname><given-names>EF</given-names></name><name><surname>Foster</surname><given-names>JA</given-names></name><name><surname>Macri</surname><given-names>J</given-names></name><name><surname>Potter</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><etal/></person-group><article-title xml:lang="en">Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice</article-title><source>Gastroenterology</source><year>2010</year><volume>139</volume><fpage>2102</fpage><lpage>2112</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsFakt73E</pub-id><pub-id pub-id-type="pmid">20600016</pub-id><pub-id pub-id-type="doi">10.1053/j.gastro.2010.06.063</pub-id><pub-id pub-id-type="pmcid">20600016</pub-id><comment>e1</comment></mixed-citation></ref><ref id="CR114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>CM</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>van Pijkeren</surname><given-names>JP</given-names></name><name><surname>Hemarajata</surname><given-names>P</given-names></name><name><surname>Trinh</surname><given-names>DV</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><etal/></person-group><article-title xml:lang="en">Histamine derived from probiotic <italic>Lactobacillus reuteri</italic> suppresses TNF via modulation of PKA and ERK signaling</article-title><source>PLoS One</source><year>2012</year><volume>7</volume><fpage>e31951</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XjsVejtbw%3D</pub-id><pub-id pub-id-type="pmid">22384111</pub-id><pub-id pub-id-type="pmcid">3285189</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0031951</pub-id></mixed-citation></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elenkov</surname><given-names>IJ</given-names></name><name><surname>Webster</surname><given-names>E</given-names></name><name><surname>Papanicolaou</surname><given-names>DA</given-names></name><name><surname>Fleisher</surname><given-names>TA</given-names></name><name><surname>Chrousos</surname><given-names>GP</given-names></name><name><surname>Wilder</surname><given-names>RL</given-names></name></person-group><article-title xml:lang="en">Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors</article-title><source>J Immunol</source><year>1998</year><volume>161</volume><fpage>2586</fpage><lpage>2593</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK1cXlslamsL4%3D</pub-id><pub-id pub-id-type="pmid">9725260</pub-id><pub-id pub-id-type="pmcid">9725260</pub-id></mixed-citation></ref><ref id="CR116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baronio</surname><given-names>D</given-names></name><name><surname>Gonchoroski</surname><given-names>T</given-names></name><name><surname>Castro</surname><given-names>K</given-names></name><name><surname>Zanatta</surname><given-names>G</given-names></name><name><surname>Gottfried</surname><given-names>C</given-names></name><name><surname>Riesgo</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Histaminergic system in brain disorders: lessons from the translational approach and future perspectives</article-title><source>Ann General Psychiatry</source><year>2014</year><volume>13</volume><fpage>34</fpage><pub-id pub-id-type="doi">10.1186/s12991-014-0034-y</pub-id></mixed-citation></ref><ref id="CR117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuutinen</surname><given-names>S</given-names></name><name><surname>Panula</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">Histamine in neurotransmission and brain diseases</article-title><source>Adv Exp Med Biol</source><year>2010</year><volume>709</volume><fpage>95</fpage><lpage>107</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhtVCltrrL</pub-id><pub-id pub-id-type="pmid">21618891</pub-id><pub-id pub-id-type="doi">10.1007/978-1-4419-8056-4_10</pub-id><pub-id pub-id-type="pmcid">21618891</pub-id></mixed-citation></ref><ref id="CR118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>D.E.</given-names></name><name><surname>Beery</surname><given-names>J.T.</given-names></name><name><surname>Lyons</surname><given-names>S.A.</given-names></name><name><surname>Taylor</surname><given-names>S.L.</given-names></name></person-group><article-title xml:lang="en">Cadaverine and aminoguanidine potentiate the uptake of histamine in vitro in perfused intestinal segments of rats</article-title><source>Toxicology and Applied Pharmacology</source><year>1983</year><volume>70</volume><issue>3</issue><fpage>445</fpage><lpage>458</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL3sXmtFWhu7Y%3D</pub-id><pub-id pub-id-type="pmid">6636174</pub-id><pub-id pub-id-type="doi">10.1016/0041-008X(83)90162-X</pub-id><pub-id pub-id-type="pmcid">6636174</pub-id></mixed-citation></ref><ref id="CR119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Gall</surname><given-names>G</given-names></name><name><surname>Noor</surname><given-names>SO</given-names></name><name><surname>Ridgway</surname><given-names>K</given-names></name><name><surname>Scovell</surname><given-names>L</given-names></name><name><surname>Jamieson</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>IT</given-names></name><etal/></person-group><article-title xml:lang="en">Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome</article-title><source>J Proteome Res</source><year>2011</year><volume>10</volume><fpage>4208</fpage><lpage>4218</lpage><pub-id pub-id-type="pmid">21761941</pub-id><pub-id pub-id-type="doi">10.1021/pr2003598</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXpvVyhtL4%3D</pub-id><pub-id pub-id-type="pmcid">21761941</pub-id></mixed-citation></ref><ref id="CR120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Bai</surname><given-names>M</given-names></name><name><surname>Peng</surname><given-names>C</given-names></name><etal/></person-group><article-title xml:lang="en">Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism</article-title><source>Front Cell Infect Microbiol</source><year>2018</year><volume>8</volume><fpage>13</fpage><pub-id pub-id-type="pmid">29468141</pub-id><pub-id pub-id-type="pmcid">5808205</pub-id><pub-id pub-id-type="doi">10.3389/fcimb.2018.00013</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXnvFSluro%3D</pub-id></mixed-citation></ref><ref id="CR121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tourino</surname><given-names>MC</given-names></name><name><surname>de Oliveira</surname><given-names>EM</given-names></name><name><surname>Bellé</surname><given-names>LP</given-names></name><name><surname>Knebel</surname><given-names>FH</given-names></name><name><surname>Albuquerque</surname><given-names>RC</given-names></name><name><surname>Dörr</surname><given-names>FA</given-names></name><etal/></person-group><article-title xml:lang="en">Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells</article-title><source>Cell Biochem Funct</source><year>2013</year><volume>31</volume><fpage>361</fpage><lpage>364</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtVeitbnM</pub-id><pub-id pub-id-type="pmid">23754498</pub-id><pub-id pub-id-type="doi">10.1002/cbf.2980</pub-id><pub-id pub-id-type="pmcid">23754498</pub-id></mixed-citation></ref><ref id="CR122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>J</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>null</surname><given-names>A</given-names></name><name><surname>Hirahara</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">Dietary tryptophan alleviates dextran sodium sulfate-induced colitis through aryl hydrocarbon receptor in mice</article-title><source>J Nutr Biochem</source><year>2017</year><volume>42</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtlGktb8%3D</pub-id><pub-id pub-id-type="pmid">28113104</pub-id><pub-id pub-id-type="doi">10.1016/j.jnutbio.2016.12.019</pub-id><pub-id pub-id-type="pmcid">28113104</pub-id></mixed-citation></ref><ref id="CR123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>M</given-names></name><name><surname>Mawe</surname><given-names>GM</given-names></name><name><surname>Barasch</surname><given-names>JM</given-names></name><name><surname>Gershon</surname><given-names>MD</given-names></name><name><surname>Gershon</surname><given-names>MD</given-names></name></person-group><article-title xml:lang="en">Physiological responses of guinea-pig myenteric neurons secondary to the release of endogenous serotonin by tryptamine</article-title><source>Neuroscience</source><year>1985</year><volume>16</volume><fpage>223</fpage><lpage>240</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL28Xmt1KgsA%3D%3D</pub-id><pub-id pub-id-type="pmid">2940472</pub-id><pub-id pub-id-type="doi">10.1016/0306-4522(85)90059-4</pub-id><pub-id pub-id-type="pmcid">2940472</pub-id></mixed-citation></ref><ref id="CR124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>JM</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Donaldson</surname><given-names>GP</given-names></name><name><surname>Shastri</surname><given-names>GG</given-names></name><name><surname>Ann</surname><given-names>P</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><etal/></person-group><article-title xml:lang="en">Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis</article-title><source>Cell</source><year>2015</year><volume>161</volume><fpage>264</fpage><lpage>276</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXmsVWqsLk%3D</pub-id><pub-id pub-id-type="pmid">25860609</pub-id><pub-id pub-id-type="pmcid">4393509</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2015.02.047</pub-id></mixed-citation></ref><ref id="CR125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linden</surname><given-names>DR</given-names></name><name><surname>Foley</surname><given-names>KF</given-names></name><name><surname>McQuoid</surname><given-names>C</given-names></name><name><surname>Simpson</surname><given-names>J</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>Mawe</surname><given-names>GM</given-names></name></person-group><article-title xml:lang="en">Serotonin transporter function and expression are reduced in mice with TNBS-induced colitis</article-title><source>Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc</source><year>2005</year><volume>17</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD2MvhsFyrsg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2982.2005.00673.x</pub-id></mixed-citation></ref><ref id="CR126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stasi</surname><given-names>C</given-names></name><name><surname>Bellini</surname><given-names>M</given-names></name><name><surname>Bassotti</surname><given-names>G</given-names></name><name><surname>Blandizzi</surname><given-names>C</given-names></name><name><surname>Milani</surname><given-names>S</given-names></name></person-group><article-title xml:lang="en">Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome</article-title><source>Tech Coloproctol</source><year>2014</year><volume>18</volume><fpage>613</fpage><lpage>621</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC2czlt1Kmug%3D%3D</pub-id><pub-id pub-id-type="pmid">24425100</pub-id><pub-id pub-id-type="doi">10.1007/s10151-013-1106-8</pub-id><pub-id pub-id-type="pmcid">24425100</pub-id></mixed-citation></ref><ref id="CR127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramage</surname><given-names>AG</given-names></name><name><surname>Villalón</surname><given-names>CM</given-names></name></person-group><article-title xml:lang="en">5-hydroxytryptamine and cardiovascular regulation</article-title><source>Trends Pharmacol Sci</source><year>2008</year><volume>29</volume><fpage>472</fpage><lpage>481</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXhtVKnurrL</pub-id><pub-id pub-id-type="pmid">19086344</pub-id><pub-id pub-id-type="doi">10.1016/j.tips.2008.06.009</pub-id><pub-id pub-id-type="pmcid">19086344</pub-id></mixed-citation></ref><ref id="CR128"><label>128.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducy</surname><given-names>P</given-names></name><name><surname>Karsenty</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">The two faces of serotonin in bone biology</article-title><source>J Cell Biol</source><year>2010</year><volume>191</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXht12isLjM</pub-id><pub-id pub-id-type="pmid">20921133</pub-id><pub-id pub-id-type="pmcid">2953449</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201006123</pub-id></mixed-citation></ref><ref id="CR129"><label>129.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>AB</given-names></name><name><surname>Yassour</surname><given-names>M</given-names></name><name><surname>Sauk</surname><given-names>J</given-names></name><name><surname>Garner</surname><given-names>A</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Arthur</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">A novel <italic>Ruminococcus gnavus</italic> clade enriched in inflammatory bowel disease patients</article-title><source>Genome Med</source><year>2017</year><volume>9</volume><fpage>103</fpage><pub-id pub-id-type="pmid">29183332</pub-id><pub-id pub-id-type="pmcid">5704459</pub-id><pub-id pub-id-type="doi">10.1186/s13073-017-0490-5</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXit1Wrs7bI</pub-id></mixed-citation></ref><ref id="CR130"><label>130.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>BB</given-names></name><name><surname>Van Benschoten</surname><given-names>AH</given-names></name><name><surname>Cimermancic</surname><given-names>P</given-names></name><name><surname>Donia</surname><given-names>MS</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Taketani</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine</article-title><source>Cell Host Microbe</source><year>2014</year><volume>16</volume><fpage>495</fpage><lpage>503</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhs1agt7zI</pub-id><pub-id pub-id-type="pmid">25263219</pub-id><pub-id pub-id-type="pmcid">4260654</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2014.09.001</pub-id></mixed-citation></ref><ref id="CR131"><label>131.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bansal</surname><given-names>T</given-names></name><name><surname>Alaniz</surname><given-names>RC</given-names></name><name><surname>Wood</surname><given-names>TK</given-names></name><name><surname>Jayaraman</surname><given-names>A</given-names></name></person-group><article-title xml:lang="en">The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXnsFCltg%3D%3D</pub-id><pub-id pub-id-type="pmid">19966295</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0906112107</pub-id><pub-id pub-id-type="pmcid">19966295</pub-id></mixed-citation></ref><ref id="CR132"><label>132.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimerel</surname><given-names>C</given-names></name><name><surname>Emery</surname><given-names>E</given-names></name><name><surname>Summers</surname><given-names>DK</given-names></name><name><surname>Keyser</surname><given-names>U</given-names></name><name><surname>Gribble</surname><given-names>FM</given-names></name><name><surname>Reimann</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Bacterial metabolite indole modulates incretin secretion from intestinal Enteroendocrine L cells</article-title><source>Cell Rep</source><year>2014</year><volume>9</volume><fpage>1202</fpage><lpage>1208</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhvFGit7fO</pub-id><pub-id pub-id-type="pmid">25456122</pub-id><pub-id pub-id-type="pmcid">4308618</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2014.10.032</pub-id></mixed-citation></ref><ref id="CR133"><label>133.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinert</surname><given-names>RE</given-names></name><name><surname>Beglinger</surname><given-names>C</given-names></name><name><surname>Langhans</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Intestinal GLP-1 and satiation: from man to rodents and back</article-title><source>Int J Obes</source><year>2016</year><volume>40</volume><fpage>198</fpage><lpage>205</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhs1Cht7vK</pub-id><pub-id pub-id-type="doi">10.1038/ijo.2015.172</pub-id></mixed-citation></ref><ref id="CR134"><label>134.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Young</surname><given-names>KD</given-names></name></person-group><article-title xml:lang="en">Indole production by the tryptophanase TnaA in <italic>Escherichia coli</italic> is determined by the amount of exogenous tryptophan</article-title><source>Microbiol Read Engl</source><year>2013</year><volume>159</volume><fpage>402</fpage><lpage>410</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXjvFOhurs%3D</pub-id><pub-id pub-id-type="doi">10.1099/mic.0.064139-0</pub-id></mixed-citation></ref><ref id="CR135"><label>135.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijers</surname><given-names>BKI</given-names></name><name><surname>Evenepoel</surname><given-names>P</given-names></name></person-group><article-title xml:lang="en">The gut–kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression</article-title><source>Nephrol Dial Transplant</source><year>2011</year><volume>26</volume><fpage>759</fpage><lpage>761</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXis1eisL8%3D</pub-id><pub-id pub-id-type="pmid">21343587</pub-id><pub-id pub-id-type="doi">10.1093/ndt/gfq818</pub-id><pub-id pub-id-type="pmcid">21343587</pub-id></mixed-citation></ref><ref id="CR136"><label>136.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcobal</surname><given-names>A</given-names></name><name><surname>De las Rivas</surname><given-names>B</given-names></name><name><surname>Landete</surname><given-names>JM</given-names></name><name><surname>Tabera</surname><given-names>L</given-names></name><name><surname>Muñoz</surname><given-names>R</given-names></name></person-group><article-title xml:lang="en">Tyramine and phenylethylamine biosynthesis by food bacteria</article-title><source>Crit Rev Food Sci Nutr</source><year>2012</year><volume>52</volume><fpage>448</fpage><lpage>467</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xms1Wgt7o%3D</pub-id><pub-id pub-id-type="pmid">22369263</pub-id><pub-id pub-id-type="doi">10.1080/10408398.2010.500545</pub-id><pub-id pub-id-type="pmcid">22369263</pub-id></mixed-citation></ref><ref id="CR137"><label>137.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalaby</surname><given-names>AR</given-names></name></person-group><article-title xml:lang="en">Significance of biogenic amines to food safety and human health</article-title><source>Food Res Int</source><year>1996</year><volume>29</volume><fpage>675</fpage><lpage>690</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2sXit1ygtL8%3D</pub-id><pub-id pub-id-type="doi">10.1016/S0963-9969(96)00066-X</pub-id></mixed-citation></ref><ref id="CR138"><label>138.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedersen</surname><given-names>G</given-names></name><name><surname>Brynskov</surname><given-names>J</given-names></name><name><surname>Saermark</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Phenol toxicity and conjugation in human colonic epithelial cells</article-title><source>Scand J Gastroenterol</source><year>2002</year><volume>37</volume><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD38XhsVWmt7o%3D</pub-id><pub-id pub-id-type="pmid">11843040</pub-id><pub-id pub-id-type="doi">10.1080/003655202753387392</pub-id><pub-id pub-id-type="pmcid">11843040</pub-id></mixed-citation></ref><ref id="CR139"><label>139.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCall</surname><given-names>IC</given-names></name><name><surname>Betanzos</surname><given-names>A</given-names></name><name><surname>Weber</surname><given-names>DA</given-names></name><name><surname>Nava</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>GW</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name></person-group><article-title xml:lang="en">Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization</article-title><source>Toxicol Appl Pharmacol</source><year>2009</year><volume>241</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXhtlWitL7I</pub-id><pub-id pub-id-type="pmid">19679145</pub-id><pub-id pub-id-type="pmcid">2877281</pub-id><pub-id pub-id-type="doi">10.1016/j.taap.2009.08.002</pub-id></mixed-citation></ref><ref id="CR140"><label>140.</label><mixed-citation publication-type="other">Saito Y, Sato T, Nomoto K, Tsuji H. Identification of phenol- and p-cresol-producing intestinal bacteria by using media supplemented with tyrosine and its metabolites. FEMS Microbiol Ecol. 2018;94 <ext-link xlink:href="https://doi.org/10.1093/femsec/fiy125" ext-link-type="doi">https://doi.org/10.1093/femsec/fiy125</ext-link>.</mixed-citation></ref><ref id="CR141"><label>141.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andriamihaja</surname><given-names>M</given-names></name><name><surname>Lan</surname><given-names>A</given-names></name><name><surname>Beaumont</surname><given-names>M</given-names></name><name><surname>Audebert</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>X</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><etal/></person-group><article-title xml:lang="en">The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells</article-title><source>Free Radic Biol Med</source><year>2015</year><volume>85</volume><fpage>219</fpage><lpage>227</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXos1Orsr0%3D</pub-id><pub-id pub-id-type="pmid">25881551</pub-id><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2015.04.004</pub-id><pub-id pub-id-type="pmcid">25881551</pub-id></mixed-citation></ref><ref id="CR142"><label>142.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiba</surname><given-names>T</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Makino</surname><given-names>I</given-names></name><name><surname>Kato</surname><given-names>I</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><etal/></person-group><article-title xml:lang="en">Effects of intestinal bacteria-derived p-cresyl sulfate on Th1-type immune response <italic>in vivo</italic> and <italic>in vitro</italic></article-title><source>Toxicol Appl Pharmacol</source><year>2014</year><volume>274</volume><fpage>191</fpage><lpage>199</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXksFGgsw%3D%3D</pub-id><pub-id pub-id-type="pmid">24161588</pub-id><pub-id pub-id-type="doi">10.1016/j.taap.2013.10.016</pub-id><pub-id pub-id-type="pmcid">24161588</pub-id></mixed-citation></ref><ref id="CR143"><label>143.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishna</surname><given-names>BS</given-names></name><name><surname>Roberts-Thomson</surname><given-names>IC</given-names></name><name><surname>Pannall</surname><given-names>PR</given-names></name><name><surname>Roediger</surname><given-names>WE</given-names></name></person-group><article-title xml:lang="en">Impaired sulphation of phenol by the colonic mucosa in quiescent and active ulcerative colitis</article-title><source>Gut</source><year>1991</year><volume>32</volume><fpage>46</fpage><lpage>49</lpage><pub-id pub-id-type="coi">1:STN:280:DyaK3M7it1Kktw%3D%3D</pub-id><pub-id pub-id-type="pmid">1991638</pub-id><pub-id pub-id-type="pmcid">1379212</pub-id><pub-id pub-id-type="doi">10.1136/gut.32.1.46</pub-id></mixed-citation></ref><ref id="CR144"><label>144.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Miyamoto</surname><given-names>Y</given-names></name><name><surname>Honda</surname><given-names>D</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Endo</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">P-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase</article-title><source>Kidney Int</source><year>2013</year><volume>83</volume><fpage>582</fpage><lpage>592</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXltVWru7c%3D</pub-id><pub-id pub-id-type="pmid">23325087</pub-id><pub-id pub-id-type="doi">10.1038/ki.2012.448</pub-id><pub-id pub-id-type="pmcid">23325087</pub-id></mixed-citation></ref><ref id="CR145"><label>145.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabriele</surname><given-names>S</given-names></name><name><surname>Sacco</surname><given-names>R</given-names></name><name><surname>Cerullo</surname><given-names>S</given-names></name><name><surname>Neri</surname><given-names>C</given-names></name><name><surname>Urbani</surname><given-names>A</given-names></name><name><surname>Tripi</surname><given-names>G</given-names></name><etal/></person-group><article-title xml:lang="en">Urinary p-cresol is elevated in young French children with autism spectrum disorder: a replication study</article-title><source>Biomarkers</source><year>2014</year><volume>19</volume><fpage>463</fpage><lpage>470</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2cXhtlOmsrzE</pub-id><pub-id pub-id-type="doi">10.3109/1354750X.2014.936911</pub-id></mixed-citation></ref><ref id="CR146"><label>146.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimazu</surname><given-names>S</given-names></name><name><surname>Miklya</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Pharmacological studies with endogenous enhancer substances: beta-phenylethylamine, tryptamine, and their synthetic derivatives</article-title><source>Prog Neuro-Psychopharmacol Biol Psychiatry</source><year>2004</year><volume>28</volume><fpage>421</fpage><lpage>427</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXjt1Siu7o%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.pnpbp.2003.11.016</pub-id></mixed-citation></ref><ref id="CR147"><label>147.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoru</surname><given-names>ML</given-names></name><name><surname>Piras</surname><given-names>C</given-names></name><name><surname>Murgia</surname><given-names>A</given-names></name><name><surname>Palmas</surname><given-names>V</given-names></name><name><surname>Camboni</surname><given-names>T</given-names></name><name><surname>Liggi</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>9523</fpage><pub-id pub-id-type="pmid">28842640</pub-id><pub-id pub-id-type="pmcid">5573342</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-10034-5</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhsl2jsb7M</pub-id></mixed-citation></ref><ref id="CR148"><label>148.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>TA</given-names></name></person-group><article-title xml:lang="en">Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism</article-title><source>FEBS Lett</source><year>2012</year><volume>586</volume><fpage>956</fpage><lpage>961</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xjslemtbw%3D</pub-id><pub-id pub-id-type="pmid">22306194</pub-id><pub-id pub-id-type="doi">10.1016/j.febslet.2012.01.049</pub-id><pub-id pub-id-type="pmcid">22306194</pub-id></mixed-citation></ref><ref id="CR149"><label>149.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>CW</given-names></name><name><surname>Lambert</surname><given-names>MA</given-names></name><name><surname>Goldsmith</surname><given-names>DJ</given-names></name></person-group><article-title xml:lang="en">Production of Hydrocinnamic acid by clostridia</article-title><source>Appl Microbiol</source><year>1970</year><volume>19</volume><fpage>375</fpage><lpage>378</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaE3cXhtVyjtLk%3D</pub-id><pub-id pub-id-type="pmid">5437307</pub-id><pub-id pub-id-type="pmcid">376686</pub-id></mixed-citation></ref><ref id="CR150"><label>150.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>MA</given-names></name><name><surname>Moss</surname><given-names>CW</given-names></name></person-group><article-title xml:lang="en">Production of p-hydroxyhydrocinnamic acid from tyrosine by Peptostreptococcus anaerobius</article-title><source>J Clin Microbiol</source><year>1980</year><volume>12</volume><fpage>291</fpage><lpage>293</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaL3cXlt1ymtLs%3D</pub-id><pub-id pub-id-type="pmid">7229012</pub-id><pub-id pub-id-type="pmcid">273571</pub-id></mixed-citation></ref><ref id="CR151"><label>151.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>W</given-names></name></person-group><article-title xml:lang="en">Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia</article-title><source>Nutr Neurosci</source><year>2010</year><volume>13</volume><fpage>135</fpage><lpage>143</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsVSqs7rI</pub-id><pub-id pub-id-type="doi">10.1179/147683010X12611460763968</pub-id></mixed-citation></ref><ref id="CR152"><label>152.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lis</surname><given-names>AW</given-names></name><name><surname>Mclaughlin</surname><given-names>I</given-names></name><name><surname>Mpclaughlin</surname><given-names>RK</given-names></name><name><surname>Lis</surname><given-names>EW</given-names></name><name><surname>Stubbs</surname><given-names>EG</given-names></name></person-group><article-title xml:lang="en">Profiles of ultraviolet-absorbing components of urine from autistic children, as obtained by high-resolution ion-exchange chromatography</article-title><source>Clin Chem</source><year>1976</year><volume>22</volume><fpage>1528</fpage><lpage>1532</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaE28XlsVSqtb0%3D</pub-id></mixed-citation></ref><ref id="CR153"><label>153.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title xml:lang="en">Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>635</fpage><pub-id pub-id-type="pmid">29330424</pub-id><pub-id pub-id-type="pmcid">5766622</pub-id><pub-id pub-id-type="doi">10.1038/s41598-017-18756-2</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXhtVOjs74%3D</pub-id></mixed-citation></ref><ref id="CR154"><label>154.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duynhoven</surname><given-names>J</given-names></name><name><surname>Vaughan</surname><given-names>EE</given-names></name><name><surname>van Dorsten</surname><given-names>F</given-names></name><name><surname>Gomez-Roldan</surname><given-names>V</given-names></name><name><surname>de Vos</surname><given-names>R</given-names></name><name><surname>Vervoort</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Interactions of black tea polyphenols with human gut microbiota: implications for gut and cardiovascular health</article-title><source>Am J Clin Nutr</source><year>2013</year><volume>98</volume><fpage>1631S</fpage><lpage>1641S</lpage><pub-id pub-id-type="pmid">24172295</pub-id><pub-id pub-id-type="doi">10.3945/ajcn.113.058263</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhvVKjsbzM</pub-id><pub-id pub-id-type="pmcid">24172295</pub-id></mixed-citation></ref><ref id="CR155"><label>155.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luceri</surname><given-names>C</given-names></name><name><surname>Giannini</surname><given-names>L</given-names></name><name><surname>Lodovici</surname><given-names>M</given-names></name><name><surname>Antonucci</surname><given-names>E</given-names></name><name><surname>Abbate</surname><given-names>R</given-names></name><name><surname>Masini</surname><given-names>E</given-names></name><etal/></person-group><article-title xml:lang="en">p-Coumaric acid, a common dietary phenol, inhibits platelet activity <italic>in vitro</italic> and <italic>in vivo</italic></article-title><source>Br J Nutr</source><year>2007</year><volume>97</volume><fpage>458</fpage><lpage>463</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXjvVSiur8%3D</pub-id><pub-id pub-id-type="pmid">17313706</pub-id><pub-id pub-id-type="doi">10.1017/S0007114507657882</pub-id><pub-id pub-id-type="pmcid">17313706</pub-id></mixed-citation></ref><ref id="CR156"><label>156.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>H</given-names></name><name><surname>Høy</surname><given-names>C-E</given-names></name></person-group><article-title xml:lang="en">The digestion of dietary triacylglycerols</article-title><source>Prog Lipid Res</source><year>2004</year><volume>43</volume><fpage>105</fpage><lpage>133</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD3sXptlyhtbo%3D</pub-id><pub-id pub-id-type="pmid">14654090</pub-id><pub-id pub-id-type="doi">10.1016/S0163-7827(03)00050-X</pub-id><pub-id pub-id-type="pmcid">14654090</pub-id></mixed-citation></ref><ref id="CR157"><label>157.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeger</surname><given-names>KE</given-names></name><name><surname>Ransac</surname><given-names>S</given-names></name><name><surname>Dijkstra</surname><given-names>BW</given-names></name><name><surname>Colson</surname><given-names>C</given-names></name><name><surname>van Heuvel</surname><given-names>M</given-names></name><name><surname>Misset</surname><given-names>O</given-names></name></person-group><article-title xml:lang="en">Bacterial lipases</article-title><source>FEMS Microbiol Rev</source><year>1994</year><volume>15</volume><fpage>29</fpage><lpage>63</lpage><pub-id pub-id-type="coi">1:CAS:528:DyaK2cXmsV2js7s%3D</pub-id><pub-id pub-id-type="pmid">7946464</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-6976.1994.tb00121.x</pub-id><pub-id pub-id-type="pmcid">7946464</pub-id></mixed-citation></ref><ref id="CR158"><label>158.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J</given-names></name><name><surname>Hussain</surname><given-names>MM</given-names></name></person-group><article-title xml:lang="en">Intestinal lipid absorption</article-title><source>Am J Physiol - Endocrinol Metab</source><year>2009</year><volume>296</volume><fpage>E1183</fpage><lpage>E1194</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1MXnsVCltrY%3D</pub-id><pub-id pub-id-type="pmid">19158321</pub-id><pub-id pub-id-type="pmcid">2692399</pub-id><pub-id pub-id-type="doi">10.1152/ajpendo.90899.2008</pub-id></mixed-citation></ref><ref id="CR159"><label>159.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Weirdt</surname><given-names>R</given-names></name><name><surname>Possemiers</surname><given-names>S</given-names></name><name><surname>Vermeulen</surname><given-names>G</given-names></name><name><surname>Moerdijk-Poortvliet</surname><given-names>TCW</given-names></name><name><surname>Boschker</surname><given-names>HTS</given-names></name><name><surname>Verstraete</surname><given-names>W</given-names></name><etal/></person-group><article-title xml:lang="en">Human faecal microbiota display variable patterns of glycerol metabolism</article-title><source>FEMS Microbiol Ecol</source><year>2010</year><volume>74</volume><fpage>601</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">20946352</pub-id><pub-id pub-id-type="doi">10.1111/j.1574-6941.2010.00974.x</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhsFKmsrvJ</pub-id><pub-id pub-id-type="pmcid">20946352</pub-id></mixed-citation></ref><ref id="CR160"><label>160.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanhaecke</surname><given-names>L</given-names></name><name><surname>Vercruysse</surname><given-names>F</given-names></name><name><surname>Boon</surname><given-names>N</given-names></name><name><surname>Verstraete</surname><given-names>W</given-names></name><name><surname>Cleenwerck</surname><given-names>I</given-names></name><name><surname>Wachter</surname><given-names>MD</given-names></name><etal/></person-group><article-title xml:lang="en">Isolation and characterization of human intestinal bacteria capable of transforming the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine</article-title><source>Appl Env Microbiol</source><year>2008</year><volume>74</volume><fpage>1469</fpage><lpage>1477</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXjt1aktLc%3D</pub-id><pub-id pub-id-type="doi">10.1128/AEM.02064-07</pub-id></mixed-citation></ref><ref id="CR161"><label>161.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleusix</surname><given-names>V</given-names></name><name><surname>Lacroix</surname><given-names>C</given-names></name><name><surname>Vollenweider</surname><given-names>S</given-names></name><name><surname>Duboux</surname><given-names>M</given-names></name><name><surname>Le Blay</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Inhibitory activity spectrum of reuterin produced by <italic>Lactobacillus reuteri</italic> against intestinal bacteria</article-title><source>BMC Microbiol</source><year>2007</year><volume>7</volume><fpage>101</fpage><pub-id pub-id-type="pmid">17997816</pub-id><pub-id pub-id-type="pmcid">2222629</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-7-101</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXnslWksw%3D%3D</pub-id></mixed-citation></ref><ref id="CR162"><label>162.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rath</surname><given-names>S</given-names></name><name><surname>Heidrich</surname><given-names>B</given-names></name><name><surname>Pieper</surname><given-names>DH</given-names></name><name><surname>Vital</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Uncovering the trimethylamine-producing bacteria of the human gut microbiota</article-title><source>Microbiome</source><year>2017</year><volume>5</volume><fpage>54</fpage><pub-id pub-id-type="pmid">28506279</pub-id><pub-id pub-id-type="pmcid">5433236</pub-id><pub-id pub-id-type="doi">10.1186/s40168-017-0271-9</pub-id></mixed-citation></ref><ref id="CR163"><label>163.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romano</surname><given-names>KA</given-names></name><name><surname>Vivas</surname><given-names>EI</given-names></name><name><surname>Amador-Noguez</surname><given-names>D</given-names></name><name><surname>Rey</surname><given-names>FE</given-names></name></person-group><article-title xml:lang="en">Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide</article-title><source>mBio</source><year>2015</year><volume>6</volume><fpage>e02481</fpage><pub-id pub-id-type="pmid">25784704</pub-id><pub-id pub-id-type="pmcid">4453578</pub-id><pub-id pub-id-type="doi">10.1128/mBio.02481-14</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXht1ejsbjI</pub-id></mixed-citation></ref><ref id="CR164"><label>164.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Klipfell</surname><given-names>E</given-names></name><name><surname>Bennett</surname><given-names>BJ</given-names></name><name><surname>Koeth</surname><given-names>R</given-names></name><name><surname>Levison</surname><given-names>BS</given-names></name><name><surname>DuGar</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title><source>Nature</source><year>2011</year><volume>472</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXksVCrsrw%3D</pub-id><pub-id pub-id-type="pmid">3086762</pub-id><pub-id pub-id-type="pmcid">3086762</pub-id><pub-id pub-id-type="doi">10.1038/nature09922</pub-id></mixed-citation></ref><ref id="CR165"><label>165.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koeth</surname><given-names>RA</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Levison</surname><given-names>BS</given-names></name><name><surname>Buffa</surname><given-names>JA</given-names></name><name><surname>Org</surname><given-names>E</given-names></name><name><surname>Sheehy</surname><given-names>BT</given-names></name><etal/></person-group><article-title xml:lang="en">Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis</article-title><source>Nat Med</source><year>2013</year><volume>19</volume><fpage>576</fpage><lpage>585</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXlsVCqu7w%3D</pub-id><pub-id pub-id-type="pmid">23563705</pub-id><pub-id pub-id-type="pmcid">3650111</pub-id><pub-id pub-id-type="doi">10.1038/nm.3145</pub-id></mixed-citation></ref><ref id="CR166"><label>166.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>You</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>T</given-names></name><name><surname>Xiang</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies</article-title><source>J Cell Mol Med</source><year>2018</year><volume>22</volume><fpage>185</fpage><lpage>194</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXit1Cluw%3D%3D</pub-id><pub-id pub-id-type="pmid">28782886</pub-id><pub-id pub-id-type="doi">10.1111/jcmm.13307</pub-id><pub-id pub-id-type="pmcid">28782886</pub-id></mixed-citation></ref><ref id="CR167"><label>167.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randrianarisoa</surname><given-names>E</given-names></name><name><surname>Lehn-Stefan</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Hoene</surname><given-names>M</given-names></name><name><surname>Peter</surname><given-names>A</given-names></name><name><surname>Heinzmann</surname><given-names>SS</given-names></name><etal/></person-group><article-title xml:lang="en">Relationship of serum trimethylamine N-oxide (TMAO) levels with early atherosclerosis in humans</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>26745</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XptVSkt7g%3D</pub-id><pub-id pub-id-type="pmid">27228955</pub-id><pub-id pub-id-type="pmcid">4882652</pub-id><pub-id pub-id-type="doi">10.1038/srep26745</pub-id></mixed-citation></ref><ref id="CR168"><label>168.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fennema</surname><given-names>D</given-names></name><name><surname>Phillips</surname><given-names>IR</given-names></name><name><surname>Shephard</surname><given-names>EA</given-names></name></person-group><article-title xml:lang="en">Trimethylamine and trimethylamine N-oxide, a Flavin-containing monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease</article-title><source>Drug Metab Dispos</source><year>2016</year><volume>44</volume><fpage>1839</fpage><lpage>1850</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtlKruro%3D</pub-id><pub-id pub-id-type="pmid">27190056</pub-id><pub-id pub-id-type="pmcid">5074467</pub-id><pub-id pub-id-type="doi">10.1124/dmd.116.070615</pub-id></mixed-citation></ref><ref id="CR169"><label>169.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cândido</surname><given-names>FG</given-names></name><name><surname>Valente</surname><given-names>FX</given-names></name><name><surname>Grześkowiak</surname><given-names>ŁM</given-names></name><name><surname>Moreira</surname><given-names>APB</given-names></name><name><surname>Rocha</surname><given-names>DMUP</given-names></name><name><surname>Alfenas R de</surname><given-names>CG</given-names></name></person-group><article-title xml:lang="en">Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity</article-title><source>Int J Food Sci Nutr</source><year>2018</year><volume>69</volume><fpage>125</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">28675945</pub-id><pub-id pub-id-type="doi">10.1080/09637486.2017.1343286</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXhtFartrrP</pub-id><pub-id pub-id-type="pmcid">28675945</pub-id></mixed-citation></ref><ref id="CR170"><label>170.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desbois</surname><given-names>AP</given-names></name><name><surname>Smith</surname><given-names>VJ</given-names></name></person-group><article-title xml:lang="en">Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential</article-title><source>Appl Microbiol Biotechnol</source><year>2010</year><volume>85</volume><fpage>1629</fpage><lpage>1642</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtVaqu7s%3D</pub-id><pub-id pub-id-type="pmid">19956944</pub-id><pub-id pub-id-type="doi">10.1007/s00253-009-2355-3</pub-id><pub-id pub-id-type="pmcid">19956944</pub-id></mixed-citation></ref><ref id="CR171"><label>171.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S</given-names></name><name><surname>Rutkowsky</surname><given-names>JM</given-names></name><name><surname>Snodgrass</surname><given-names>RG</given-names></name><name><surname>Ono-Moore</surname><given-names>KD</given-names></name><name><surname>Schneider</surname><given-names>DA</given-names></name><name><surname>Newman</surname><given-names>JW</given-names></name><etal/></person-group><article-title xml:lang="en">Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways</article-title><source>J Lipid Res</source><year>2012</year><volume>53</volume><fpage>2002</fpage><lpage>2013</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xht1GhsL%2FJ</pub-id><pub-id pub-id-type="pmid">22766885</pub-id><pub-id pub-id-type="pmcid">22766885</pub-id><pub-id pub-id-type="doi">10.1194/jlr.D029546</pub-id></mixed-citation></ref><ref id="CR172"><label>172.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name></person-group><article-title xml:lang="en">N-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions</article-title><source>Proc Nutr Soc</source><year>2013</year><volume>72</volume><fpage>326</fpage><lpage>336</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtFOis7jK</pub-id><pub-id pub-id-type="pmid">23668691</pub-id><pub-id pub-id-type="doi">10.1017/S0029665113001031</pub-id><pub-id pub-id-type="pmcid">23668691</pub-id></mixed-citation></ref><ref id="CR173"><label>173.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregor</surname><given-names>MF</given-names></name><name><surname>Hotamisligil</surname><given-names>GS</given-names></name></person-group><article-title xml:lang="en">Inflammatory mechanisms in obesity</article-title><source>Annu Rev Immunol</source><year>2011</year><volume>29</volume><fpage>415</fpage><lpage>445</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXltlKnsL8%3D</pub-id><pub-id pub-id-type="pmid">21219177</pub-id><pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101322</pub-id><pub-id pub-id-type="pmcid">21219177</pub-id></mixed-citation></ref><ref id="CR174"><label>174.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bäckhed</surname><given-names>F</given-names></name><name><surname>Manchester</surname><given-names>JK</given-names></name><name><surname>Semenkovich</surname><given-names>CF</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group><article-title xml:lang="en">Mechanisms underlying the resistance to diet-induced obesity in germ-free mice</article-title><source>Proc Natl Acad Sci U S A</source><year>2007</year><volume>104</volume><fpage>979</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">17210919</pub-id><pub-id pub-id-type="pmcid">1764762</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0605374104</pub-id><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXhtVSitbo%3D</pub-id></mixed-citation></ref><ref id="CR175"><label>175.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>MS</given-names></name><name><surname>Seekatz</surname><given-names>AM</given-names></name><name><surname>Koropatkin</surname><given-names>NM</given-names></name><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Hickey</surname><given-names>CA</given-names></name><name><surname>Wolter</surname><given-names>M</given-names></name><etal/></person-group><article-title xml:lang="en">A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility</article-title><source>Cell</source><year>2016</year><volume>167</volume><fpage>1339</fpage><lpage>1353</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhvFWgu7nM</pub-id><pub-id pub-id-type="pmid">27863247</pub-id><pub-id pub-id-type="pmcid">5131798</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.043</pub-id><comment>e21</comment></mixed-citation></ref><ref id="CR176"><label>176.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>FitzGerald</surname><given-names>GA</given-names></name></person-group><article-title xml:lang="en">Timing the microbes: the circadian rhythm of the gut microbiome</article-title><source>J Biol Rhythm</source><year>2017</year><volume>32</volume><fpage>505</fpage><lpage>515</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1MXislSrsLo%3D</pub-id><pub-id pub-id-type="doi">10.1177/0748730417729066</pub-id></mixed-citation></ref><ref id="CR177"><label>177.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Png</surname><given-names>CW</given-names></name><name><surname>Lindén</surname><given-names>SK</given-names></name><name><surname>Gilshenan</surname><given-names>KS</given-names></name><name><surname>Zoetendal</surname><given-names>EG</given-names></name><name><surname>McSweeney</surname><given-names>CS</given-names></name><name><surname>Sly</surname><given-names>LI</given-names></name><etal/></person-group><article-title xml:lang="en">Mucolytic bacteria with increased prevalence in IBD mucosa augment <italic>in vitro</italic> utilization of mucin by other bacteria</article-title><source>Am J Gastroenterol</source><year>2010</year><volume>105</volume><fpage>2420</fpage><lpage>2428</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtlOhsb7J</pub-id><pub-id pub-id-type="pmid">20648002</pub-id><pub-id pub-id-type="doi">10.1038/ajg.2010.281</pub-id><pub-id pub-id-type="pmcid">20648002</pub-id></mixed-citation></ref><ref id="CR178"><label>178.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dao</surname><given-names>MC</given-names></name><name><surname>Everard</surname><given-names>A</given-names></name><name><surname>Aron-Wisnewsky</surname><given-names>J</given-names></name><name><surname>Sokolovska</surname><given-names>N</given-names></name><name><surname>Prifti</surname><given-names>E</given-names></name><name><surname>Verger</surname><given-names>EO</given-names></name><etal/></person-group><article-title xml:lang="en"><italic>Akkermansia muciniphila</italic> and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology</article-title><source>Gut</source><year>2016</year><volume>65</volume><fpage>426</fpage><lpage>436</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2sXivV2mt7Y%3D</pub-id><pub-id pub-id-type="pmid">26100928</pub-id><pub-id pub-id-type="doi">10.1136/gutjnl-2014-308778</pub-id><pub-id pub-id-type="pmcid">26100928</pub-id></mixed-citation></ref><ref id="CR179"><label>179.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everard</surname><given-names>A</given-names></name><name><surname>Belzer</surname><given-names>C</given-names></name><name><surname>Geurts</surname><given-names>L</given-names></name><name><surname>Ouwerkerk</surname><given-names>JP</given-names></name><name><surname>Druart</surname><given-names>C</given-names></name><name><surname>Bindels</surname><given-names>LB</given-names></name><etal/></person-group><article-title xml:lang="en">Cross-talk between <italic>Akkermansia muciniphila</italic> and intestinal epithelium controls diet-induced obesity</article-title><source>Proc Natl Acad Sci</source><year>2013</year><volume>110</volume><fpage>9066</fpage><lpage>9071</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtFait7rM</pub-id><pub-id pub-id-type="pmid">23671105</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1219451110</pub-id><pub-id pub-id-type="pmcid">23671105</pub-id></mixed-citation></ref><ref id="CR180"><label>180.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devkota</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Musch</surname><given-names>M</given-names></name><name><surname>Leone</surname><given-names>V</given-names></name><name><surname>Fehlner-Peach</surname><given-names>H</given-names></name><name><surname>Nadimpalli</surname><given-names>A</given-names></name><etal/></person-group><article-title xml:lang="en">Dietary fat-induced taurocholic acid production promotes pathobiont and colitis in IL-10−/− mice</article-title><source>Nature</source><year>2012</year><volume>487</volume><fpage>104</fpage><lpage>108</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XpvVSmsLc%3D</pub-id><pub-id pub-id-type="pmid">22722865</pub-id><pub-id pub-id-type="pmcid">3393783</pub-id><pub-id pub-id-type="doi">10.1038/nature11225</pub-id></mixed-citation></ref><ref id="CR181"><label>181.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staley</surname><given-names>C</given-names></name><name><surname>Weingarden</surname><given-names>AR</given-names></name><name><surname>Khoruts</surname><given-names>A</given-names></name><name><surname>Sadowsky</surname><given-names>MJ</given-names></name></person-group><article-title xml:lang="en">Interaction of gut microbiota with bile acid metabolism and its influence on disease states</article-title><source>Appl Microbiol Biotechnol</source><year>2017</year><volume>101</volume><fpage>47</fpage><lpage>64</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC28XhvFCiur7K</pub-id><pub-id pub-id-type="pmid">27888332</pub-id><pub-id pub-id-type="doi">10.1007/s00253-016-8006-6</pub-id><pub-id pub-id-type="pmcid">27888332</pub-id></mixed-citation></ref><ref id="CR182"><label>182.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carabotti</surname><given-names>M</given-names></name><name><surname>Scirocco</surname><given-names>A</given-names></name><name><surname>Maselli</surname><given-names>MA</given-names></name><name><surname>Severi</surname><given-names>C</given-names></name></person-group><article-title xml:lang="en">The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems</article-title><source>Ann Gastroenterol</source><year>2015</year><volume>28</volume><fpage>203</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">4367209</pub-id><pub-id pub-id-type="pmcid">4367209</pub-id></mixed-citation></ref><ref id="CR183"><label>183.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>A</given-names></name><name><surname>Debelius</surname><given-names>J</given-names></name><name><surname>Brenner</surname><given-names>DA</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name><name><surname>Loomba</surname><given-names>R</given-names></name><name><surname>Schnabl</surname><given-names>B</given-names></name><etal/></person-group><article-title xml:lang="en">The gut–liver axis and the intersection with the microbiome</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2018</year><volume>15</volume><fpage>397</fpage><lpage>411</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXpsVWks7o%3D</pub-id><pub-id pub-id-type="pmid">29748586</pub-id><pub-id pub-id-type="pmcid">6319369</pub-id><pub-id pub-id-type="doi">10.1038/s41575-018-0011-z</pub-id></mixed-citation></ref><ref id="CR184"><label>184.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamo</surname><given-names>T</given-names></name><name><surname>Akazawa</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>J</given-names></name><name><surname>Komuro</surname><given-names>I</given-names></name></person-group><article-title xml:lang="en">Novel concept of a heart-gut axis in the pathophysiology of heart failure</article-title><source>Korean Circ J</source><year>2017</year><volume>47</volume><fpage>663</fpage><lpage>669</lpage><pub-id pub-id-type="pmid">28955383</pub-id><pub-id pub-id-type="pmcid">5614941</pub-id><pub-id pub-id-type="doi">10.4070/kcj.2017.0028</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1"><sec id="Sec12"><title>Additional files</title><p id="Par37"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Additional files"><media xlink:href="MediaObjects/40168_2019_704_MOESM1_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Pathways of basic amino acid fermentation by the human gut microbiome. Pathways have been simplifed to show major end-products. Where ‘SCFA’ is listed, either acetate, propionate or butyrate can result from catabolism of the substrate. (PDF 181 kb)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" xlink:title="Additional files"><media xlink:href="MediaObjects/40168_2019_704_MOESM2_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption xml:lang="en"><p>Pathways of aromatic amino acid fermentation by the human gut microbiome. Pathways have been simplified to show major end-products. Where ‘SCFA’ is listed, either acetate, propionate or butyrate can result from catabolism of the substrate. (PDF 174 kb)</p></caption></media></supplementary-material></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>APC</term><def><p id="Par2">Antigen presenting cell</p></def></def-item><def-item><term>BCFA</term><def><p id="Par3">Branched-chain fatty acid</p></def></def-item><def-item><term>GABA</term><def><p id="Par4">4-Aminobutryate</p></def></def-item><def-item><term>GI</term><def><p id="Par5">Gastrointestinal</p></def></def-item><def-item><term>IBD</term><def><p id="Par6">Inflammatory bowel disease</p></def></def-item><def-item><term>IBS</term><def><p id="Par7">Irritable bowel syndrome</p></def></def-item><def-item><term>IEC</term><def><p id="Par8">Intestinal epithelial cell</p></def></def-item><def-item><term>NAFLD</term><def><p id="Par9">Non-alcoholic fatty liver disease</p></def></def-item><def-item><term>SCFA</term><def><p id="Par10">Short-chain fatty acid</p></def></def-item><def-item><term>TLR</term><def><p id="Par11">Toll-like receptor</p></def></def-item><def-item><term>UC</term><def><p id="Par12">Ulcerative colitis</p></def></def-item></def-list></glossary></back></article></records><facets><facet name="subject"><facet-value count="1">Bioinformatics</facet-value><facet-value count="1">Biomedicine</facet-value><facet-value count="1">Medical Microbiology</facet-value><facet-value count="1">Microbial Ecology</facet-value><facet-value count="1">Microbial Genetics and Genomics</facet-value><facet-value count="1">Microbiology</facet-value><facet-value count="1">Virology</facet-value></facet><facet name="keyword"><facet-value count="1">Human gut microbiome</facet-value><facet-value count="1">Human health</facet-value><facet-value count="1">Macronutrients</facet-value><facet-value count="1">Microbial metabolism</facet-value></facet><facet name="pub"><facet-value count="1">Microbiome</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Canada</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
